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Actinobacillus pleuropneumoniae is a small, Gram-negative capsulated rod with typical 
coccobacillary morphology (Nicolet, 1992; Shope et al., 1964). A. pleuropneumoniae causes 
porcine pleuropneumonia, a disease that has serious impact on the economy in most pig-
rearing countries (Nicolet, 1992). Infection of pigs with A. pleuropneumoniae is considered 
one of the most important causes of acute respiratory disease in pigs and can result in high 
morbidity and mortality (Cruijsen, 1995, 1996; Loeffen et al., 1999; Nicolet, 1992). In 
addition to losses due to mortality, infection with A. pleuropneumoniae can be costly due 
to higher medication costs, reduced feed conversion, lower weaning rates, and reduced 
market value of animals. While individual animals can be examined for clinical symptoms 
and pathological alterations, infections with A. pleuropneumoniae at the herd level can 
be diagnosed by measurement of antibodies against A. pleuropneumoniae in for example 
enzyme linked immuno sorbent assays or complement fixation tests. Alternatively, bacteria 
can be cultured from typical lung lesions.
A. pleuropneumoniae strains can be differentiated into strains that depend on nicotinamide 
adenine dinucleotide (NAD) (biotype 1) and strains that are NAD-independent (biotype 2). 
Based on antigenic diversity of capsule and lipopolysaccharide (LPS) composition, 15 
serotypes of A. pleuropneumoniae have been identified regardless of their NAD requirement 
(Blackall et al., 2002; Schaller et al., 2001). All serotypes are haemolytic (Taylor, 1999) 
and can cause severe disease and death in pigs. Subclinically infected carriers or animals 
recovered from the disease are believed to transmit A. pleuropneumoniae within and between 
herds (Chiers et al., 2001; Møller et al., 1993; Sidibe et al., 1993). Direct transmission of 
A. pleuropneumoniae from pig to pig occurs (Velthuis et al., 2002) and is believed to be 
an important infection route, since the bacterium can not survive for a long time in the 
environment (Nicolet, 1992).
The pathology of pleuropneumonia is characterised by a fibrinous pleuritis and a fibrino-
haemorrhagic necrotising pneumonia with focal pulmonary vascular thrombosis (Nicolet, 
1992). Pulmonary lesions are characterised by severe oedema, inflammation, haemorrhage 
and necrosis (Ajito et al., 1996; Bertram, 1985; Rosendal et al., 1985). Marked infiltration 
of polymorphonuclear leucocytes (PMNs), oedema, and fibrinous exudate are apparent in 
the early stages of disease (Ajito et al., 1996; Bertram, 1985; Liggett et al., 1987). Infection 
of pigs with A. pleuropneumoniae leads to a rapid local production of the proinflammatory 
cytokines tumor necrosis factor α (TNFα), interleukin (IL) 1, IL 6 and the potent PMN 
chemoattractant IL 8 (Baarsch et al., 1995; Baarsch et al., 2000; Huang et al., 1999). TNFα, 
IL 1 and IL 8 are pivotal in the development of lung inflammation and cell infiltration. 
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Rapid recruitment and activation of PMNs leads to a release of toxic oxygen radicals and 
proteolytic enzymes (Dom et al., 1992b) which can result in deleterious effects on host 
cells. Tissue damage and activation of neutrophils and macrophages have been attributed 
to toxins produced by A. pleuropneumoniae (Dom et al., 1992a; Dom et al., 1992b; Dom 
et al., 1994a; Jansen et al., 1995; Kamp et al., 1997). In vivo, A. pleuropneumoniae can be 
found within alveolar and interlobular fluid and within alveolar macrophages and PMNs 
(Min and Chae, 1998). Epithelial cells are not invaded by A. pleuropneumoniae (Min and 
Chae, 1998). A. pleuropneumoniae mainly colonises the lower respiratory tract, but the 
bacterium can be isolated from tonsils of chronically infected animals (Møller et al., 1993; 
Mousing et al., 1990; Sidibe et al., 1993). Experimental epidemiological studies showed a 
high correlation between infectivity of pigs and tonsils positive for A. pleuropneumoniae at 
necropsy (Velthuis et al., 2002), but the role of tonsils in the pathogenesis is unclear. The 
disease can be reproduced in animal models that involve aerosol, intranasal or endobronchial 
exposure of pigs (Hensel et al., 1995; Liggett et al., 1987; Van Leengoed and Kamp, 1989) 
which mimic in various degrees the natural infection route of respiratory tract infections. 
Aerosol application by a nose-only exposure system and endobronchial infection are highly 
reproducible and well standardised.
To control A. pleuropneumoniae infections in pigs, several different vaccines are being 
used. Immunisation with killed bacteria provides at least serotype-specific protection 
(Nielsen, 1984; Rosendal et al., 1981; Thacker and Mulks, 1988). Improvements have been 
made by subunit vaccines containing the RTX toxins ApxI, ApxII and ApxIII which induce 
good protection against clinical disease caused by any serotype (Fedorka-Cray et al., 1993; 
Kamp et al., 1992; van den Bosch et al., 1992; van Leengoed, 1988). Although these vaccines 
reduce mortality and morbidity, they do not prevent the development of colonisation nor 
transmission (Beskow et al., 1993; Chiers et al., 1998; Hensel et al., 2000; Møller et al., 
1993; Van Overbeke et al., 2001; Velthuis et al., 2002). Prevention or a sufficient reduction of 
colonisation may lead to eradication of A. pleuropneumoniae from a population. Protection 
against clinical disease was achieved with several of the known virulence factors but never 
complete. Together, more information concerning the role of virulence factors is required to 
improve available vaccines against A. pleuropneumoniae.
The molecular pathogenesis of A. pleuropneumoniae infections is not completely 
understood. Several virulence factors have been described that contribute to microbial fitness 
in the host and to the pathogenesis (Bosse et al., 2002; Haesebrouck et al., 1997) and will be 
discussed below. For establishment of infection, A. pleuropneumoniae needs to colonise and 
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to evade the host defence system. Therefore, we divided the virulence factors in colonisation 
factors and bacterial attack and defence factors. This is not a strict division since some 
virulence factors exhibit more than one property.
COLONISATION FACTORS
Adherence
In general, adherence of micro-organisms to epithelial cells is regarded as the initial step 
in the colonisation of the host and often involves a specific interaction between bacterial 
adhesins and complementary receptors on host cells (Hoepelman and Tuomanen, 1992; 
Hultgren et al., 1993). By attaching to host cells, microbes are thought to avoid elimination 
by e.g. mucociliary clearance. The attached state possibly enhances their toxicity to the host, 
their resistance to deleterious agents, their ability to trap nutrients and allows the bacteria to 
multiply more efficiently than do unattached bacterial cells (Cundel, 1995; Svanborg et al., 
1996). Host or tissue specificity in adherence may be explained by the presence of specific 
receptors that interact with distinct adhesins present at the bacterial cell surface.
A. pleuropneumoniae adheres in vitro to porcine tracheal and lung cells (Belanger et 
al., 1990; Jacques et al., 1991; Paradis et al., 1994; Paradis et al., 1999), mucus of the 
respiratory tract (Belanger et al., 1992; Belanger et al., 1994) and to methanol-fixed alveolar 
epithelial cells (Haesebrouck et al., 1996; Van Overbeke et al., 2002). In vivo after intranasal 
inoculation, A. pleuropneumoniae has been shown to be associated predominantly with the 
cilia of terminal bronchioli and the epithelium of alveoli and only sporadically with the cilia 
or the epithelium of the bronchi and trachea (Dom et al., 1994a), suggesting that lung cells 
may be a primary infection target.
Information on adhesins of A. pleuropneumoniae is limited. LPS has been suggested 
to play a role in adherence of A. pleuropneumoniae. LPS is a major constituent of the 
outer membrane of Gram-negative bacteria and consists of lipid A and a polysaccharide 
moiety containing O-antigen and core region (Hitchcock et al., 1986). Adherence of 
A. pleuropneumoniae to tracheal and lung tissue could be inhibited with purified LPS, 
fractionated high-molecular-mass polysaccharide and with monoclonal antibodies directed 
against the O-antigen of LPS (Belanger et al., 1990; Paradis et al., 1994; Paradis et al., 
1999). Further adherence studies suggested that the core region of LPS acts as an adhesin, 
a function that is masked by the O-antigen (Abul-Milh et al., 1999; Rioux et al., 1999). 
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Inhibition studies of A. pleuropneumoniae adherence to alveolar epithelial cells indicated 
that both LPS and proteins are involved in adherence (Van Overbeke et al., 2002). However, 
proteins that mediate adherence of A. pleuropneumoniae have not been identified so far. 
Many bacterial pathogens carry fimbriae that can mediate adherence of bacteria to host cells 
(Gilsdorf et al., 1996; Hahn, 1997; Nassif et al., 1994; Strom and Lory, 1993). Fimbriae or 
pili are filamentous polymeric structures that protrude from the bacterial cell surface (Wu and 
Fives-Taylor, 2001). Recently, fimbriae have been isolated from A. pleuropneumoniae and 
were found to belong to the type IV family of fimbriae (Zhang et al., 2000). The role of these 
fimbriae in the pathogenesis of A. pleuropneumoniae remains to be elucidated.
Bacterial metabolism
For efficient colonisation or establishment of infection, bacteria must be able to acquire 
all essential nutrients. Within the host, the variety and quantity of available nutrients is 
restricted depending on the niche (MacFadyen and Redfield, 1996). The ability to overcome 
these nutritional limitations within the host may be considered a virulence trait. Iron is the 
most important nutrient used by bacteria since it is needed as a cofactor for a large number 
of metabolic enzymes. Due to complexation by the host glycoproteins transferrin and 
lactoferrin, iron is not readily available in the extracellular environment of the host. Many 
bacterial pathogens overcome this iron-restriction by expressing receptor proteins at the 
bacterial surface involved in direct binding of the host’s transferrin or bacterial siderophores. 
A. pleuropneumoniae produces two distinct transferrin binding proteins (TbpA and TbpB) 
that are both required for optimal utilisation of transferrin as a sole source of iron and for 
virulence (Baltes et al., 2002; Fuller et al., 1998; Gonzalez et al., 1990; Litt et al., 2000; 
Ricard et al., 1991). The restriction of the transferrin binding proteins to porcine transferrin 
(Niven et al., 1989) may explain the host specifitiy of A. pleuropneumoniae. Recently, 
a ferric hydroxamate uptake (fhu) operon has been identified that putatively encodes a 
second iron acquisition mechanism (Mikael et al., 2002). Although there are indications 
that FhuA is expressed in vivo (Mikael et al., 2002), FhuA is not required for virulence of A. 
pleuropneumoniae (Baltes et al., 2003). After binding at the bacterial cell surface, transport 
of iron across the outer membrane is enabled by a protein complex of ExbB, ExbD and TonB 
(Moeck and Coulton, 1998). Mutants in exbB or tonB of A. pleuropneumoniae are avirulent, 
demonstrating the essential role of this complex in iron acquisition in vivo (Baltes et al., 
2001; Fuller et al., 2000).
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Additional virulence genes of A. pleuropneumoniae have been identified with signature 
tagged mutagenesis (STM) and in vivo expression technology (IVET) (Fuller et al., 1999; 
Fuller et al., 2000). Genes identified by STM represented five broad functional classes: 
biosynthetic enzymes, putative colonisation factors, cellular regulation components, 
translation components and unknowns (Fuller et al., 2000). In the IVET study, ten loci were 
identified that were specifically induced in vivo (Fuller et al., 1999), but information on the 
correspondingly induced genes is limited. Further analysis of all loci identified with STM and 
IVET will likely lead to new insights into the pathogenesis of A. pleuropneumoniae.
BACTERIAL DEFENCE AND ATTACK FACTORS
During infection, bacteria are subject to phagocytosis by macrophages and PMNs and 
to killing by antibody and complement. Most pathogens have the ability to counteract these 
activities. A. pleuropneumoniae produces several factors involved in defence and attack 
which may have concomitant destructive effects on host tissue.
Toxins
A major factor involved in impairment of host-defence mechanisms is the production 
of exotoxin. Many Gram-negative bacteria that are human or animal pathogens, including 
A. pleuropneumoniae, produce extracellular pore forming toxins belonging to the RTX 
(repeats in toxin) family (Welch et al., 1995). There are many indications that RTX toxins 
play a role in the evasion of the host’s first line of defence, i.e. phagocytosis and killing 
by macrophages and neutrophils (Welch, 1991; Welch et al., 1995). A. pleuropneumoniae 
produces four different toxins belonging to the RTX family, named ApxI, ApxII, ApxIII 
and ApxIV (Frey et al., 1993; Schaller et al., 1999). The toxins ApxI, ApxII and ApxIII are 
essential for the development of clinical disease and the typical lung lesions (Anderson et al., 
1991; Inzana, 1991; Kamp et al., 1997; Reimer et al., 1995; Tascon et al., 1994). These three 
toxins are expressed both in vitro and in vivo and are in various degrees cytotoxic for lung 
macrophages, PMNs, lung epithelial cells and endothelial cells (Bendixen et al., 1981; Dom 
et al., 1992a; Dom et al., 1992b, 1994b; Kamp et al., 1991; Serebrin et al., 1991; Tarigan 
et al., 1994; Van de Kerkhof et al., 1996; Van Leengoed and Kamp, 1989). ApxI and ApxII 
are also haemolytic. ApxIV in A. pleuropneumoniae is expressed in vivo only and when 
expressed in Eschericha coli it is weakly haemolytic (Schaller et al., 1999). The contribution 
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of ApxIV to the pathogenesis is not clear 
since bacteria deficient in ApxI, ApxII and 
ApxIII but producing ApxIV are not able 
to cause lesions or disease (Reimer et al., 
1995; Tascon et al., 1994).
The ability of A. pleuropneumoniae to 
produce multiple Apx toxins varies between 
serotypes (Table 1). The surplus value of 
the production of more than one toxin is 
unknown. It may account for the variation in 
virulence among A. pleuropneumoniae strains. ApxII appears to contribute to a lesser extent 
than ApxI and ApxIII to lesion formation in animal experiments with purified toxins and to 
in vitro toxicity (Kamp et al., 1991; Kamp et al., 1997). However, strains of serotype 7 and 
mutants of serotype 1 and 5 which produce only ApxII and ApxIV, are capable of causing 
severe disease with typical lung lesions (Reimer et al., 1995; Tascon et al., 1994). This 
prompts the question, what the relative contribution in the pathogenesis is of the different 
toxins in a given serotype.
Capsule
Many bacterial pathogens produce a capsule that protects the bacterium against the 
immune system of the host (Moxon and Kroll, 1990). All serotypes of A. pleuropneumoniae 
produce a capsule which mainly consists of derivatised repeating oligosaccharides (Beynon 
et al., 1993; Perry et al., 1990). Non-encapsulated mutants of A. pleuropneumoniae were 
considerably less virulent compared to their capsulated parent strains (Inzana et al., 1993; 
Rioux et al., 2000; Rosendal and MacInnes, 1990; Ward et al., 1998). Capsule protects the 
bacterium against killing by antibody and complement by limiting the deposition of C9, a 
component of the membrane attack complex (Rycroft and Cullen, 1990; Ward and Inzana, 
1994). High-molecular-weight surface carbohydrates present in capsule and LPS may 
participate in scavenging of free oxygen radicals (Bilinski, 1991). Because of the protective 
capacities of capsule, phagocytosis and subsequent killing of A. pleuropneumoniae by PMNs 
requires opsonisation with antibody (Cruijsen et al., 1992; Inzana et al., 1988).
Table 1 Distribution of Apx toxins in A. 
pleuropneumoniae strains of biovar 1
Serotype Secreted Apx toxins in 
vivo
1, 5, 9, 11 I II IV
10 I IV
2, 3, 4, 6, 8 II III IV
7, 12 II IV
This table was compiled using data from Frey et 
al. (1993) and Schaller et al. (1999).
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Lipopolysaccharide 
LPS, present at the bacterial surface, contributes to complement resistance by binding 
LPS-specific antibodies in a fashion that does not result in the formation of a functional 
complement membrane attack complex (Ward and Inzana, 1994). Purified LPS of A. 
pleuropneumoniae has all characteristics of endotoxin and, through activation of factor 
XII, initiates coagulation and fibrinolysis which ultimately results in necrosis (Fenwick and 
Osburn, 1986; Fenwick et al., 1986; Maudsley et al., 1986; Udeze et al., 1987). Purified LPS 
is able to induce lung lesions that are similar to lesions induced by A. pleuropneumoniae or 
purified toxins although the typical haemorrhagic necrosis is missing and large amounts are 
required (Fenwick and Osburn, 1986; Fenwick et al., 1986; Maudsley et al., 1986; Udeze et 
al., 1987). The contribution of LPS in the development of lesions is not clear. Infection with a 
mutant strain lacking ApxI and ApxII but with normal LPS did not result in lesions or clinical 
disease (Tascon et al., 1994). Possibly, the inflammatory responses induced by LPS (Huang 
et al., 1999; Lin et al., 1994; Ulich et al., 1991) may explain the similarity of lesions induced 
by purified LPS and toxins.
Urease
Urease is a potential contributor to survival in the host and is produced by virtually all 
strains of A. pleuropneumoniae. Urease hydrolyses urea to ammonia which has been shown 
to inhibit phagosome-lysosome fusion and to elevate intralysosomal pH in macrophages, 
resulting in depression of acid hydrolase (Gordon et al., 1980). Urease negative mutants 
of A. pleuropneumoniae were still able to produce acute infection at a high challenge dose 
(105-106 CFU/ml in aerosol infection) but not at a low challenge dose (103 CFU/ml in aerosol 
infection) (Baltes et al., 2001; Bosse and MacInnes, 2000). The latter could be due to the 
rapid clearance of urease negative mutants compared to the wild-type strain (Baltes et al., 
2001; Bosse and MacInnes, 2000).
Proteolytic activity
Immunoglobulin A (IgA) is a major class of immunoglobulin present in the mucosa of 
the healthy respiratory tract and is thought to be the most important immunoglobulin for 
lung defence (Lamm, 1997). IgA in respiratory secretions can bind via its carbohydrate 
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moieties to lectinlike bacterial adhesins, thereby blocking their epithelial colonisation. 
Several micro-organisms colonising mucosal surfaces, including A. pleuropneumoniae, 
produce proteases which are capable of cleaving secretory IgA antibodies (Kilian et al., 
1988; O’Reilly and Bhatti, 1986; Plaut, 1983) thereby possibly enhancing survival of the 
micro-organism. In addition to IgA, A. pleuropneumoniae is able to degrade IgG, porcine 
gelatin and haemoglobin (Negrete-Abascal et al., 1994; Negrete-Abascal et al., 1998). 
The specificity and the contribution to the pathogenesis of these proteolytic activities of A. 
pleuropneumoniae is unclear.
Superoxide dismutase
During the course of infection, many bacterial pathogens are exposed to high levels of 
oxygen radicals generated by inflammatory cells during oxidative burst. The capacity of 
superoxide dismutases (SODs) to degrade exogenous superoxide suggests a role of these 
enzymes in the pathogenesis. A. pleuropneumoniae contains a periplasmic copper-zinc 
superoxide dismutase (SodC) (Langford et al., 1996). Although a SodC deficient mutant 
of A. pleuropneumoniae was highly sensitive to the microbial action of superoxide in 
vitro, it remained fully virulent in pigs (Sheehan et al., 2000). Possibly, SodC activity is 
complemented by redundant oxidoreductase activities which compensate for the defect in 
sodC.
SCOPE AND OUTLINE OF THIS THESIS
As discussed above, for improvement of control strategies, more knowledge is needed 
about virulence factors contributing to survival of A. pleuropneumoniae in vivo. In this study, 
we investigated the relative contribution of two distinct toxins of A. pleuropneumoniae 
serotype 1 (ApxI and ApxII) in the development of lesions (Chapter 2). To study the adherence 
of A. pleuropneumoniae, we set out to design an in vitro adherence model using lung epithelial 
cells (Chapter 3). Adherence is regarded as an important first step in the colonisation and 
subsequent infection of the host, but little is known about factors contributing to adherence 
of A. pleuropneumoniae. In our search for possible adhesins of A. pleuropneumoniae, we 
focused on the type IV fimbriae recently identified in A. pleuropneumoniae. Fimbriae have 
been implicated in adherence of various species and purified fimbriae have been shown to 
confer protection. The entire type IV fimbriae operon of A. pleuropneumoniae serotype 1 was 
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cloned and characterised (Chapter 4) and the conditions driving fimbriae expression were 
studied (Chapter 5). The significance of these findings for the pathogenesis are discussed in 
Chapter 6.
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ABSTRACT
Most serotypes of Actinobacillus pleuropneumoniae produce in vivo more than one toxin. 
To determine the surplus value of the production of more than one toxin in the development 
of disease, we tested the pathogenicity in vivo of isogenic strains of A. pleuropneumoniae 
serotype 1 that are mutated in the toxin genes apxIA and/or apxIIA or in the toxin transport 
genes apxIBD. Bacteria mutated in both apxIA and  apxIIA or in apxIBD were not able to 
induce pathological lesions, indicating that ApxI and ApxII are essential for the pathogenesis 
of pleuropneumonia. Infection with isogenic strains lacking either ApxI or ApxII did not 
consistently lead to pleuropneumonia in contrast to infection with the parent strain S4074. 
ApxII seemed at least as potent as ApxI for the development of clinical and pathological 
symptoms. Only one out of four pigs inoculated with an ApxII mutant strain developed mild 
pneumonia whereas two out of three pigs inoculated with an ApxI mutant strain developed 
more severe lesions. These results indicate that both ApxI and ApxII of A. pleuropneumoniae 
serotype 1 are necessary for full virulence.
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INTRODUCTION
Actinobacillus pleuropneumoniae causes porcine pleuropneumonia, a disease which 
occurs world-wide and affects growing pigs of all ages. The pathology of the disease is 
characterised by a fibrinous pleuritis and a fibrino-haemorrhagic necrotizing pneumonia 
with focal pulmonary vascular thrombosis (Nicolet, 1992). Several virulence factors of 
A. pleuropneumoniae have been described that enable the bacterium to survive in vivo 
(Haesebrouck et al., 1997). Major virulence factors are the capsule, the lipopolysaccharide 
(LPS) and the toxins. The capsule has been shown to protect against killing by antibody and 
complement and against phagocytosis by polymorphonuclear leucocytes (PMNs) (Inzana et 
al., 1988; Ward and Inzana, 1994). Smooth lipopolysaccharide (LPS) has been shown to play 
a role in adherence of A. pleuropneumoniae to lung and tracheal frozen sections (Paradis et 
al., 1994). A. pleuropneumoniae produces four different toxins belonging to the family of 
RTX toxins, named ApxI, ApxII, ApxIII and ApxIV (Kamp et al., 1991; Frey et al., 1993; 
Jansen et al., 1995; Schaller et al., 1999). In general, RTX toxins are encoded by operons that 
consist of four contiguous genes C, A, B, and D (Welch, 1991; Fath and Kolter, 1993). Genes 
C and A are required for the production of active toxin protein and genes B and D are required 
for the secretion of the active toxin. ApxI, ApxII and ApxIII are expressed in vitro and in vivo 
and are in various degrees cytotoxic for lung macrophages, PMN, lung epithelial cells and 
endothelial cells (Van Leengoed et al., 1989; Serebrin et al., 1991; Dom et al., 1994; Van de 
Kerkhof et al., 1996). ApxI and ApxII are also haemolytic. ApxIV is expressed in vivo only 
and when expressed in Eschericha coli it is weakly haemolytic (Schaller et al., 1999). ApxI, 
ApxII and ApxIII are essential for the development of clinical disease and the typical lung 
lesions because mutants that produce none of these three toxins are non-pathogenic (Tascon 
et al., 1994; Inzana, 1991; Anderson et al., 1991; Reimer et al., 1995).
All A. pleuropneumoniae serotypes contain apxIVA (Schaller et al., 1999). Serotypes 7, 
10 and 12 produce one additional Apx toxin while serotypes 1, 2, 3, 4, 5, 6, 8, 9 and 11 even 
produce two extra Apx toxins. Since disease and typical lung lesions produced by the different 
serotypes of A. pleuropneumoniae are very similar, the question arises what the surplus value 
is of the production of more than one toxin. Therefore, we tested the pathogenicity in vivo 
of isogenic strains of A. pleuropneumoniae serotype 1 that are mutated in the toxin genes 
apxIA and/or apxIIA or in the transport genes apxIBD (Jansen et al., 1995) to determine the 
contribution of ApxI and ApxII in the development of disease. The results show that the 
presence of at least ApxI or ApxII is necessary for the development of pneumonia but that the 
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combination of ApxI and ApxII enhances the virulence of A. pleuropneumoniae serotype 1.
MATERIAL AND METHODS
Bacterial strains and growth conditions A. pleuropneumoniae reference strain S4074 
(serotype 1) contains genes apxIA, apxIIA and apxIVA encoding ApxI, ApxII and ApxIV and 
was used to generate toxin mutants by targeted mutagenesis (Jansen et al., 1995). In mutant 
strain 1 (S4074 ΔapxIA) the apxIA gene was inactivated, this knockout mutant secretes in 
vitro ApxII only. In mutant strain 14 (S4074 ΔapxIIA) the apxIIA gene was inactivated, this 
knockout mutant secretes in vitro ApxI only. In mutant strain 21 (S4074 ΔapxIA ΔapxIIA) 
both the apxIA and apxIIA genes were inactivated. This double knockout mutant secretes no 
Apx toxins in vitro. In mutant strain 6 (S4074 ΔapxIBD) the apxIBD genes were inactivated 
and this knockout mutant also secretes no Apx toxins in vitro.
For preparation of the inocula, A. pleuropneumoniae strains were cultured on sheep 
blood agar plates (SB) supplemented with 0.1% ß-nicotinamide adenine dinucleotide (NAD, 
Calbiochem, La Jolla, USA), for 24 h at 37°C. Fifty colonies were suspended in 100 µl of 
Eagle’s minimal essential medium (EMEM, Gibco BRL, Paisley, UK), plated on SB+NAD 
and incubated for 6 h at 37°C. Each plate was then rinsed with 5 ml EMEM and suspensions 
were stored overnight at 4°C. To determine the number of colony forming units (CFU) of 
the bacterial suspensions, tenfold dilutions were plated on SB+NAD and incubated at 37°C. 
After 18 h, the CFU were counted, and inocula were prepared from the bacterial suspensions 
stored at 4°C overnight by dilution with phosphate-buffered saline solution (PBS; 0.123 M 
NaCl, 0.01 M Na
2
HPO
4
, 0.0032 M KH
2
PO
4
; pH 7.2) to approximately 200 CFU/ml. After 
inoculation of the pigs, the number of CFU was confirmed by plating 100 µl of the inoculum 
on SB+NAD. The average inoculum contained 640 CFU. Bacteria isolated from tissue were 
characterised on the basis of haemolytic activity on SB+NAD.
Infection experiment The experiment was performed in two similar, consecutive trials in 
specific pathogen free pigs from the ID-Lelystad breeding herd free of A. pleuropneumoniae. 
Per trial, ten pigs were randomly allocated to five groups of two pigs. The pigs of each group 
were housed in sterile stainless steel isolators. In the first trial pigs were about four weeks 
of age and in the second trial they were about eight weeks of age. Pigs were delivered to 
the experimental facilities and allowed to acclimate for four days before they were infected. 
For endobronchial infection, pigs were anaesthetised with a combination of azaperone 
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(Stresnil; Jansen Pharmaceutica B.V., Tilburg, The Netherlands) and ketamine hydrochloride 
(ketamine; Kombivet B.V., Etten-Leur, The Netherlands). Inoculation was performed as 
previously described (Van Leengoed and Kamp, 1989). Briefly, a catheter with an outer 
diameter of 2.2 mm was advanced through the trachea deep into the bronchi and 5 ml of 
bacterial suspension was slowly administered. A total of four pigs per strain was inoculated 
(divided over the two trials) with approximately 1,000 CFU of the parent strain or of one of 
the four mutants strains. An inoculation dose of 1,000 CFU of A. pleuropneumoniae serotype 
9 was sufficient to induce lesions in all animals (Van Leengoed and Kamp, 1989). In the 
group inoculated with S4074 ΔapxIA only three pigs were infected due to technical problems 
during inoculation. Pigs were monitored clinically for two days after inoculation. At 0, 6, 
12, 24, 36 and 48 hours post infection (hpi) rectal temperatures were measured and the pigs 
were inspected for clinical symptoms as depression, laboured breathing, coughing, or nasal 
discharge. All animal experiments were approved by the ethical committee of ID-Lelystad.
Clinical pathology To assess the induction and development of disease by the different 
A. pleuropneumoniae strains in the period after inoculation, blood samples were taken at 0, 
6, 12, 24, 36 and 48 hpi. White blood cells (WBC) were counted in all blood samples with 
a Sysmex microcell counter. Serum levels of interleukin (IL) 6, IL 1 and tumour necrosis 
factor (TNFα) were determined by bioassays at 0 and 12 hpi. Serum IL 6 was measured with 
a bioassay using murine B9 cells as described by Helle et al. (1988) with slight modifications. 
Briefly, B9 cells were grown until confluence was reached in Dulbecco’s modified Eagle’s 
medium (DMEM, Gibco) with 5% heat inactivated foetal bovine serum and sodium penicillin 
and streptomycin sulphate in presence of 50 U/ml human recombinant IL 6 (CLB Amsterdam, 
NL, nr. M1449). Cells were washed once with IL 6 free DMEM and suspended at 105 cells/ml 
in DMEM. Serum samples were titrated in threefold and 50 µl was added to 50 µl of B9 cells 
in flat bottom wells. Cell proliferation was measured 72 hours after incubation by tetrazolium 
dye reduction (MTT assay). Results were related to a standard curve generated by dilutions in 
threefold of human recombinant IL 6 and expressed as units/ml. A slight background reaction 
was seen before infection and this background level was subtracted from the measured value 
at 12 hpi. An increase in IL 6 level was regarded as marked when values exceeded the mean 
of all pigs at 0 hpi by more than two times the standard deviation. An increase was regarded 
as slightly when values exceeded the mean by more than one standard deviation. Serum IL 
1 was determined by using the cell proliferating capacity of IL 1 on the cloned murine T cell 
line D10 according to Helle et al. (1988) with the modification that proliferation was tested 
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by the colorimetric MTT assay. Activity of TNFα in serum samples was determined using 
WEHI 164 cells, a TNF-cytotoxic cell line, according to the modified procedures of Espevik 
and Nissen-Meyer (1986).
Pathology Forty-eight hpi pigs were anaesthetised by intravenous injection of 
pentobarbital and exsanguinated. The lungs were excised and the presence of pleuritis, 
type of lung changes and the size of lung lesions were recorded. To avoid bias, personnel 
responsible for clinical inspection and pathological examinations were not informed of the 
groups to which the animals or tissues belonged. For bacteriological examination, tissue was 
sampled from the caudal lobe of the right and left lung and from the tracheobronchial lymph 
node. For histological examination specimens were taken from both distal caudal lung lobes 
and the tracheobronchial lymph node in cases with no macroscopical lesions. If lesions were 
present, tissue specimens were taken from the centre and the periphery of altered lung tissue. 
Specimens for histological examination were fixed in ten percent neutral-buffered formaline 
for at least 48 hours. Formaline fixed lung tissue was embedded in paraffin and sectioned at 
3–5 µm and stained with hematoxylin and eosin. Immunohistological examination of lung 
tissue for in situ localisation of A. pleuropneumoniae was selectively done on lungs from pigs 
with lung lesions and on lungs from pigs that were cultured positive for A. pleuropneumoniae. 
Immunohistology was done by an indirect immunoperoxidase technique. Tissue sections 
from paraffin embedded tissue were deparaffinised, rehydrated and washed in PBS. After 
inactivating endogenous peroxidase (30 min in 3% H
2
O
2
), slides were incubated overnight 
at 4°C with a hyperimmune rabbit serum raised against A. pleuropneumoniae serotype 11 
(dilution 1:10000) in a moist chamber. The used serum was shown to cross-react with serotype 
1 (Kamp et al., 1987). To identify antibodies bound to bacteria, slides were incubated with 
biotin labelled goat anti rabbit immunesera (DAKO, Hamburg, Germany). Bound secondary 
antibodies were visualised by adding peroxidase-conjugated streptavidin (DAKO) followed 
by enzymehistochemical staining with 3,3´-diaminobenzidine tetrahydrochloride (Sigma 
Chemical Co., St. Louis, USA) and H
2
O
2
, which results in a brown staining of specific 
structures. Slides were counterstained with Mayer’s hematoxylin.
Statistical analysis Results of the different toxin mutants, expressed as the number of 
animals with pneumonic lesions after infection, were compared with results of the parent 
strain in this study and in identical previous studies with four animals per trial using Fishers 
exact test. 
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RESULTS
Parent strain S4074 Results of clinical signs, WBC count and IL 6 levels after 
endobronchial infection of pigs with A. pleuropneumoniae serotype 1 parent strain S4074 or 
deletion mutants are summarised in Table 1. The frequency and severity of pleuropneumonia 
after endobronchial infection with A. pleuropneumoniae serotype 1 parent strain S4074 or 
deletion mutants are summarised in Table 2.
Clinically, all four pigs inoculated with the parent strain showed moderate to severe 
symptoms typical of an infection with A. pleuropneumoniae with laboured breathing and/or 
coughing at 18 and 24 hours post infection (hpi). Two pigs died about 36 hpi and showed 
large lesion volumes in the lungs (255 and 277 cm3, Table 2). Clinical signs started in three 
pigs from 12 hpi on, accompanied by fever of > 40°C. At 18 hpi all pigs had developed 
fever. The mean rectal body temperature over all time points after infection was highest in 
this group compared to the other groups and fever was observed in 9 out of 18 observations 
(Table 1). The number of WBC was increased from 12 hpi on in all four pigs and stayed at 
the same level or increased further until the end of the experiment. All pigs had increased IL 
6 levels at 12 hpi (Table 1), however no correlation was found between levels of IL 6 at this 
time point and severity of pleuropneumonia. Three of the four pigs had marked elevated IL 6 
levels, ranging between 601 and 86,305 U/ml and one pig, which died early, had only slightly 
elevated IL 6 levels of 70 U/ml (Table 1). TNFα and IL 1 were detected in none of the sera 
at 12 hpi. All four pigs had a moderate to severe fibrinous, necro-haemorrhagic pneumonia 
with fibrinous pleurisy in one side of the lung (Table 2). Lesions extended over parts of the 
caudal lung lobe or in two cases over the whole right lung. From lung lesions of all pigs and 
from tracheobronchial lymph nodes of two pigs, strongly haemolytic A. pleuropneumoniae 
were isolated (Table 2). The isolated phenotype was the same as the phenotype used for 
inoculation and was characterised on the basis of haemolytic activity on SB+NAD.
S4074 ΔapxIA In contrast to the pigs inoculated with the parent strain, none of the pigs 
inoculated with mutant strain S4074 ΔapxIA died before the end of the experimental period. 
All three pigs showed at 12 or 18 hpi mild clinical depression and one pig showed respiratory 
distress at 24 and 48 hpi. Two pigs displayed fever at 24 hpi, which started in one pig already 
at 12 hpi. Both pigs with fever had an increased WBC count from 6 hpi on and had marked 
elevated serum IL 6 levels at 12 hpi (Table 1). TNFα and IL 1 were detected in none of the 
sera at 12 hpi. In each of the two trials, one pig had a typical unilateral necro-haemorrhagic 
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pneumonia with fibrinous pleuritis with an affected lung volume of 25 or 91 cm3 (Table 2). 
The presence of pleuropneumonia correlated with fever and increased serum IL 6 levels. 
From lung lesions only, weakly haemolytic A. pleuropneumoniae were isolated (Table 2). The 
isolated phenotype was the same as the phenotype used for inoculation. The increases in WBC 
count after infection in the pneumonic pigs were comparable to the increases in WBC count 
in the group infected with the parent strain, suggesting a correlation between leucocytosis 
and the presence of pneumonia. These results show that infection with A. pleuropneumoniae 
S4074 in the absence of ApxI does not consistently result in pleuropneumonia as is seen with 
the parent strain, although this was not significant (P > 0.05). In cases with pleuropneumonia, 
the clinical course is similar to that observed after infection with the parent strain.
S4074 ΔapxIIA All pigs inoculated with mutant strain S4074 ΔapxIIA survived until the 
end of the experimental period. One animal showed mild signs of depression and fever at 24 
hpi. WBC count was increased in two pigs at 6 hpi and WBC count peaked at 24–48 hpi in 
the pig that showed depression. One pig had slightly elevated serum IL 6 levels (Table 1), 
indicating the presence of an inflammatory response in the lungs of this pig after inoculation. 
In one pig IL 6 could not be determined because of haemolysis. TNFα and IL 1 were detected 
in none of the sera at 12 hpi. Only one out of the four pigs had a small focal pneumonia with 
a lesion volume of 14 cm3 (Table 2). In contrast to the lesions induced by the parent strain 
or the mutant strain S4074 ΔapxIA this was not accompanied by pleuritis. From the lung 
lesion only, strongly haemolytic A. pleuropneumoniae were isolated (Table 2). The isolated 
phenotype was the same as the phenotype used for inoculation. The pig with pathological 
lung alterations did not show an increase of IL 6 serum titer 12 hpi. This is probably due to a 
delayed induction of inflammation, which is also expressed by a delayed strong increase of 
WBC at 24−48 hpi in this pig. These results show that infection with A. pleuropneumoniae 
S4074 in the absence of ApxII does not consistently result in pneumonia as is seen with 
the parent strain (P < 0.05). In the case with pneumonia, the clinical course was delayed 
compared to that observed after infection with the parent strain.
S4074 ΔapxIA ΔapxIIA All pigs inoculated with mutant strain S4074 ΔapxIA ΔapxIIA 
survived until the end of the experimental period. Two pigs displayed mild signs of depression 
at 18 hpi and two pigs showed an increase of WBC count at 6 and 12 hpi, but none of the 
pigs developed fever (Table 1) or pneumonia. One of the pigs with clinical symptoms had a 
marked elevated serum IL 6 level at 12 hpi and the other pig had slightly elevated IL 6 serum 
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titres (Table 1). The increases in serum IL 6 levels and WBC count also express an ApxI 
and ApxII independent clinical response to the inoculation. TNFα and IL 1 were detected 
in none of the sera at 12 hpi. None of the pigs showed gross pathological lesions in contrast 
to the parent strain (P < 0.05) and no A. pleuropneumoniae with the inoculation phenotype 
were isolated (Table 2). These results demonstrate the importance of ApxI and ApxII for the 
induction of the typical lung lesions. The findings show that although ApxI and ApxII were 
not present and no lesions were evoked, a clinical reaction occurred.
S4074 ΔapxIBD To confirm the results obtained with mutant strain S4074 ΔapxIA 
ΔapxIIA, the pathogenicity of strain S4074 ΔapxIBD was tested. The absence of ApxI and 
ApxII due to the lack of the toxin secretion genes also resulted in a lack of pleuropneumonia 
and death in contrast to the parent strain (P < 0.05), thereby confirming the conclusion that 
actively secreted ApxI and ApxII are essential for the pathogenesis of pleuropneumonia. 
In the group inoculated with mutant strain S4074 ΔapxIBD, one pig showed mild signs of 
depression at 18 and 24 hpi, but none of the pigs displayed fever at any time point (Table 1). 
The pig with clinical symptoms had an increased WBC count at 18 hpi and a marked elevated 
serum IL 6 level at 12 hpi, two other pigs had slightly elevated IL 6 levels at 12 hpi (Table 
1). This also indicates an ApxI and ApxII independent clinical response. TNFα and IL 1 were 
detected in none of the sera at 12 hpi. None of the pigs showed gross pathological lesions and 
no A. pleuropneumoniae were isolated (Table 2).
Histopathology and immunohistology Typical lesions with central necrosis of lung 
tissue surrounded by a dense layer of streaming cells, fibrin extravasation in interalveolar 
septae and thrombosis of blood vessels were observed histologically in all pigs infected 
with the parent strain. Similar pathological features as central necrosis surrounded by a 
demarcation zone were found in all pigs with pneumonia inoculated with mutant strain S4074 
ΔapxIIA (Fig. 1A) or S4074 ΔapxIA. The presence of lesions correlated with the isolation of 
A. pleuropneumoniae. Immunohistological examination of lung tissue was selectively done 
on lungs from pigs with lung lesions and on lungs from pigs that were cultured positive for 
A. pleuropneumoniae. Bacteria were detected immunohistologically in macrophages and in 
large numbers around the edges of the necrotic areas adjacent to the alveolar epithelium 
(Fig. 1B) in all pigs with (pleuro)-pneumonia. Additionally, bacteria were found in smaller 
numbers outside necrotic areas adhering to alveolar epithelium (Fig. 1C) or to bronchiolar 
epithelium and in tracheal secretion. Histopathological changes were detected in none of the 
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pigs without gross pathological lesions and no A. pleuropneumoniae were isolated from pigs 
without gross pathological lesions.
DISCUSSION
In this study we determined the contribution of two Apx toxins of A. pleuropneumoniae 
serotype 1 in the induction of clinical symptoms and pneumonic lesions by using isogenic 
mutants in which one or two of the Apx toxin genes or the secretion genes had been 
inactivated. The used infection model is well established and results in lesions in all pigs 
when they are inoculated with approximately 1,000 CFU of A. pleuropneumoniae strain 
13261 of serotype 9 (Van Leengoed and Kamp, 1989). This model allows the use of small 
numbers of animals to detect differences between strains. Strain S4074 used in this study, 
was in previous experiments as virulent as strain 13261 and consistently induced comparable 
lesions (unpublished results). In this study, all four animals inoculated with parent strain 
S4074 developed typical lung lesions and moderate to severe clinical symptoms.
The consistent induction of pathological lesions depended on the presence of both ApxI 
and ApxII. Bacteria mutated in both apxIA and apxIIA and bacteria mutated in genes apxIBD 
FIG. 1. Paraffin embedded tissue sections of fibrinonecrotic pneumonia in the lung of a pig after 
infection with S4074 ΔapxIA. A) The necrotic area (indicated by an asterisk) is surrounded by a 
demarcation zone with typical “streaming cells” and polymorphonuclear leucocytes (5 × objective). 
This demarcation zone is missing after inoculation with Apx toxins only (Kamp et al., 1997). B) 
Dark brown staining of A. pleuropneumonia antigen was located predominantly in the periphery 
of the necrotic lung areas and the demarcation zone (arrow, 5 × objective). C) A. pleuropneumonia 
antigen was sporadically detected outside of necrotic lung areas adhering to alveolar epithelium 
(arrows) and alveolar macrophages (arrowheads) (20 × objective). Note the tissue hyperaemia and 
the influx of leucocytes into the alveolar lumen. Staining in Fig. 1A was done with hematoxylin and 
eosin, A. pleuropneumonia antigen in Figs 1B and 1C was made visible with a specific antibody 
in conjunction with labelled streptavidin biotin immunoperoxidase staining and hematoxylin 
counterstain.
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required for toxin secretion were not able to induce lesions. This indicates that actively 
secreted ApxI and ApxII are necessary for the development of lesions in line with previous 
observations (Tascon et al., 1994; Reimer et al., 1995). Although no pathological lesions 
were found in pigs inoculated with mutant strains unable to produce or secrete Apx toxins, 
the majority of these pigs showed increased numbers of WBC or elevated serum IL 6 levels. 
Several pigs also displayed mild clinical symptoms in the period after inoculation. The 
induction of IL 6 production and the mild clinical symptoms in these pigs, could indicate the 
presence of an infection and may have been caused by the release of other compounds like 
LPS or ApxIV. Because a saline controle was not included, a reaction due to the inoculation 
procedure can not be excluded. Export of ApxII in A. pleuropneumoniae serotype 1 is 
dependent on ApxIB and ApxID. Proteins involved in the export of ApxIV have not been 
identified yet. If export of ApxIV depends on ApxIB and ApxID, it is not likely that ApxIV 
is the cause of increased IL 6 production and mild clinical symptoms because pigs infected 
with strain S4074 ΔapxIBD also showed these reactions.
To determine the contribution of two Apx toxins of A. pleuropneumoniae serotype 1 
in the pathogenesis, isogenic mutants were used in which the toxin genes apxIA or apxIIA 
were inactivated. The presence of either ApxI or ApxII in A. pleuropneumoniae serotype 1 
appeared not to be sufficient to consistently induce pathological lesions. Bacteria that were 
mutated in either apxIA or apxIIA induced less severe lesions and/or in fewer pigs than the 
parent strain. Histologically no differences were detected between lesions caused by the ApxI 
or ApxII mutants and lesions caused by the parent strain. Mutants of serotype 1 and 5, devoid 
of ApxI but still producing ApxII also caused typical severe clinical disease (Tascon et al., 
1994; Reimer et al., 1995). However, apxIIA deletion mutants were not included in those 
studies. In our hands both ApxI and ApxII appear to be required for full virulence.
Our results indicate that ApxII is at least as potent as ApxI for the development of clinical 
and pathological symptoms. Only one out of four pigs inoculated with mutant strain S4074 
ΔapxIIA developed mild pneumonia whereas two out of three pigs inoculated with mutant 
strain S4074 ΔapxIA developed more severe lesions. These results are in contrast to other 
studies which indicated a lower toxicity or a smaller contribution to virulence for ApxII than 
for ApxI and ApxIII among all serotypes (Kamp et al., 1991; Kamp et al., 1997). The reduced 
toxicity in in vivo experiments of purified recombinant ApxII compared to ApxI and ApxIII 
(Kamp et al., 1997), should be viewed critically since the large amounts of toxins used in that 
study do not reflect the natural situation. Bacteria in close contact to cells can directly target 
the toxin to these cells whereas instillation of recombinant toxin in the lung can result in a 
CHAPTER 2
32 33
APX AND PATHOGENESIS OF A. PLEUROPNEUMONIAE
more diffuse delivery. A large portion of inactive toxin was present in the ApxII preparations 
which might reduce the overall toxicity by competition (Kamp et al., 1997). A demarcation 
zone typical for A. pleuropneumoniae infections was not found after inoculation with purified 
toxins (Kamp et al., 1997), and is probably not dependent on both toxins but related to live 
bacteria and a longer lasting host defence reaction. Little is known about the production level 
in vivo of the different toxins. 
The recently characterised ApxIV is expressed in vivo only by all serotypes of biovar 1 
(Schaller et al., 1999), including reference strain S4074 used in this study. The contribution 
of ApxIV to the development of clinical and/or pathological symptoms remains to be 
elucidated. Although we did not test it, it is very likely that ApxIV is produced in vivo by the 
parent strain and the mutant strains devoid of ApxI and/or ApxII. If this assumption is true, 
ApxIV alone is not able to induce clinical pathology. Active ApxIV requires the presence of 
an additional gene, ORF1, which is located immediately upstream of apxIVA (Schaller et al., 
1999). Whether export of ApxIV depends on ApxIB and ApxID is unknown.
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ABSTRACT
To study adherence of Actinobacillus pleuropneumoniae to porcine lower respiratory 
epithelium, a cell culture model was developed using primary cultures of porcine lung 
epithelial cells (LEC). Adherence assays were performed and results were compared with 
data obtained with swine kidney cells (SK6). A. pleuropneumoniae efficiently adhered to 
LEC with up to 62 bacteria per cell after 2 h of incubation. Reference strain of serotype 3 
(R3) adhered better to LEC than reference strains of serotypes 1 (R1), 7 (R7) and 8 (R8). 
Overall the adherence to LEC was more rapid and up to 30-fold more efficient than adherence 
to SK6 cells. In search for the mechanism involved in the adherence event, we tested the 
effect of LPS which has previously been demonstrated to cause adherence of the pathogen to 
upper respiratory epithelium. Adherence assays with LPS transposon mutants demonstrated 
unaltered (mutants with modification in core/lipid A moiety) or even three-fold more 
adherence (mutant lacking O-antigen) compared to the parent micro-organisms. Purified LPS 
of strains R1, R3, R7 and R8 did not inhibit adherence of R8 to LEC either, suggesting that 
LPS and particularly the O-antigen are not essential for adherence of A. pleuropneumoniae 
to LEC. The efficient, LPS-independent adherence of A. pleuropneumoniae to LEC cells 
indicates that A. pleuropneumoniae may carry different, cell type-specific adhesins and that 
infection of primary cultures of lower respiratory epithelium are valuable infection models in 
studying A. pleuropneumoniae pathogenesis.
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INTRODUCTION
Actinobacillus pleuropneumoniae causes porcine pleuropneumonia, a disease that 
is distributed world-wide and causes severe economic losses to the pig rearing industry 
(Barnum, 1990; Nicolet, 1992). Based on differences in capsule composition, 12 
serotypes of A. pleuropneumoniae have been identified (Nielsen, 1986). All serotypes of 
A. pleuropneumoniae can cause severe disease and death in pigs. A. pleuropneumoniae 
infections are host specific and mainly affect the lung. Several potential virulence factors 
have been identified, including polysaccharide capsule (Inzana, 1991; Tascon et al., 1996; 
Haesebrouck et al., 1997) and toxins (Frey, 1995; Kamp et al., 1997). The molecular 
pathogenesis of the infection is not completely understood. In general, adherence of micro-
organisms to epithelial cells is the initial step in the colonisation of the host and often involves 
specific interaction between bacterial adhesins and complementary receptors on host cells 
(Woods, 1988; Hoepelman and Tuomanen, 1992; Hultgren et al., 1993). Host or tissue 
specificity in adherence can be explained by different receptors that interact with distinct 
adhesins present at the bacterial cell surface. A. pleuropneumoniae has been shown to adhere 
in vitro to porcine tracheal rings (Belanger et al., 1990), frozen lung- and trachea-sections 
(Jacques et al., 1991; Paradis et al., 1994; Paradis et al., 1999), and mucus of the respiratory 
tract (Belanger et al., 1992; Belanger et al., 1994). The adherence to porcine tracheal frozen 
sections was inhibited by the polysaccharide moiety of lipopolysaccharide (LPS) (Paradis et 
al., 1994) and by monoclonal antibodies directed against the O-antigen of LPS (Paradis et 
al., 1999) suggesting that LPS is an adherence factor. In vivo after intranasal inoculation, A. 
pleuropneumoniae has been shown to be associated with the cilia of terminal bronchioli and 
the epithelium of alveoli but only sporadically with the cilia or the epithelium of the bronchi 
and trachea (Dom et al., 1994). A. pleuropneumoniae adherence to methanol-fixed alveolar 
epithelial cells has also been demonstrated (Haesebrouck et al., 1996; Van Overbeke et al., 
2000), suggesting that lung cells may be an important infection target.
The purpose of this study was to search for an appropriate A. pleuropneumoniae infection 
system to study the adherence of this pathogen to lower respiratory tract epithelium. Here 
we report that primary cultures of lung epithelial cells (LEC) are an excellent model to 
study the pathogen−host interaction. Our data indicate rapid and efficient adherence of A. 
pleuropneumoniae to this cell system via an LPS-independent process.
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MATERIALS AND METHODS
Bacterial strains and growth conditions A. pleuropneumoniae reference strains of 
serotypes 1 (S4047: R1), 3 (1421: R3), 7 (WF83: R7) and 8 (405: R8) were used. The 
LPS profiles of the strains were semirough (R1) or smooth (R3, R7 and R8). Bordetella 
bronchiseptica strain 92932, a highly adherent stain which served as a positive control, was 
isolated from a pig with atrophic rhinitis (Kamp and Kimman, 1988). Pasteurella multocida 
subspecies multocida Carter serotype D, strain NCTC 10325, a poor adherent strain, served 
as a negative control. A. pleuropneumoniae LPS transposon mutants #5.1, #15.1 and #24.1 
with a defective core (#5.1) or O- antigen (#15.1, 24#1) and their nalidixic acid-resistant 
parent strain (4074 Nalr) of serotype 1 were kindly provided by Dr. M. Jacques (University 
of Montreal, Canada). The construction of these LPS mutants has been described (Rioux et 
al., 1999).
B. bronchiseptica and P. multocida were cultured on sheep blood agar (SB) plates. A. 
pleuropneumoniae was cultured on SB plates containing 0.01% β-nicotinamide adenine 
dinucleotide (NAD, Calbiochem, La Jolla, CA, USA). The parent 4047 Nalr was cultured 
on brain heart infusion (BHI, Gibco BRL, Paisley, UK) agar plates supplemented with 
0.05% NAD and 30 µg/ml nalidixic acid (Nal, Sigma Chemical Co., St. Louis, MO, USA), 
the transposon mutants were cultured on BHI-NAD-Nal agar plates containing 75 µg/ml 
kanamycin (Km, Sigma) as described (Rioux et al., 1999). All plates were incubated at 37°C 
in a 5% CO
2
 atmosphere. For adherence tests, bacteria were grown for 18 h on agar plates, 
harvested in phosphate buffered saline (PBS: 136.89 mM NaCl, 2.68 mM KCl, 8.1 mM 
Na
2
HPO
4
, 2.79 mM K
2
HPO
4
, pH 7.2), centrifuged for 10 min at 3700 × g, and suspended in 
10 ml of Dulbecco’s modified Eagles medium (DMEM, Gibco).
Isolation and analysis of lipopolysaccharides Lipopolysaccharides were isolated by 
the method of Westphal and Jann (1965). Briefly, bacteria were extracted with hot phenol 
and aqueous layers were dialysed against water. LPS was pelleted by ultracentrifugation, 
lyophilised and dissolved in water. Purified LPS was analysed by SDS-PAGE (15% gel) 
and silverstaining (Tsai and Frasch, 1982). LPS preparations were assayed for 2-keto-3-
deoxyoctulosonic (KDO) acid released after hydrolisis of LPS using a colorimetric assay 
(Hanson and Philips, 1981) and contained 112 (R1), 152 (R3), 87 (R7), 100 (R8) and 134 
(Escherichia coli O111:B4 (Sigma)) nmol KDO per µg LPS.
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Isolation and culture of porcine lung epithelial cells (LEC) Lung epithelial cells were 
obtained from lungs of 6 weeks old pigs from our own specific pathogen free (SPF) herd. We 
used a modification of the technique of Dobbs (1990). Pigs were sedated by an intravenous 
injection of pentobarbital (Nembutal, 20 mg/kg of body weight). Additionally, heparin 
(350 IU/kg) was administered intravenously. Lungs were perfused with 2 l of PBS of 37°C 
containing 5 IU/ml heparin via the jugular vein until they were free of blood. The right cranial 
lobes were excised and washed 12 times via the main bronchus with 25 ml of solution I (140 
mM NaCl, 5 mM KCl, 2.5 mM Na
2
HPO
4
, 0.2 mM EGTA (ethylene glycol bis (β-aminoethyl 
ether)-N,N,N ,´N´´ -tetraacetate, Sigma), 10 mM HEPES (N-2-hydroxyethylpiperazine-N´-2-
ethanesulfonic acid, Gibco) and 6 mM glucose, pH 7.4) and four times with 25 ml of solution 
II (140 mM NaCl, 5 mM KCl, 2.5 mM Na
2
HPO
4
, 2 mM CaCl
2
 and 1.3 mM MgSO
4
, 10 mM 
HEPES and 6 mM glucose, pH 7.4) to remove alveolar macrophages. Lobes were inflated 
with 40 ml of elastase (from porcine pancreas, Boehringer, Mannheim, Germany, 0.76 mg/ml 
dissolved in solution II) and incubated for 30 min at 37°C. To gain epithelial cells, the lobes 
were minced with a pair of sharp scissors in approximately 1 mm3 cubes in the presence of 
0.2 mg/ml DNAse I (Sigma) and suspended in solution II containing 10% foetal calf serum 
(FCS, Biochrom KG, Berlin, Germany) to block elastase activity. After gentle shaking, the 
suspension was filtered through 200 and 50 µm polyamidmono filters (Nybolt). Cells were 
centrifuged for 20 min at 150 × g and the cell pellet was resuspended in DMEM. To remove 
residual alveolar macrophages, the cell suspension was plated onto pig IgG-coated dishes 
as described by Dobbs et al. (1986). A porcine immunoglobulin G (Sigma) solution of 50 
µg/ml was used to coat bacteriologic plastic dishes. After the plates were washed, 5 ml of 
the cell suspension was added to each plate. Plates were incubated for 2 h at 37°C in a 5% 
CO
2
 atmosphere, and unattached cells were removed and seeded at 6.7 × 104 cells/cm2. Cells 
were cultured in DMEM, 10% FCS, 2 mM glutamine (ICN, Aurora, OH, USA), 1 mM 
HEPES, 100 IU/ml penicillin and 100 µg/ml streptomycin (pen/strep) at 37°C in a 5% CO
2
 
atmosphere. When confluence was reached, cells were trypsinised, frozen in culture medium 
supplemented with 10% DMSO (Merck Diagnostica, Darmstadt, Germany), and stored in 
liquid nitrogen.
Cell characterisation Cultured lung cells were characterised by immuno-staining. Cells 
were fixed with methanol containing 0.3% H
2
O
2
 and washed with PBS. After blocking with 
normal rabbit serum (DAKO, Hamburg, Germany), cells were incubated (1 h, RT) with anti-
pan cytokeratine (Clone C-11, Sigma, 1/400 dilution), anti-vimentin (Clone LN-6, Sigma, 
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1/1000) or anti-macrophage (mAb 517.2, 1/1000 Dominguez et al., 1998). After washing, 
cells were incubated (1 h, RT) with rabbit anti-mouse horseradish peroxidase conjugate 
(DAKO, 1/1000). Bound antibodies were visualised by addition of hydrogen peroxide and 
3,3 -´diaminobenzidine tetrahydrochloride (Sigma) as chromogenic substrate. Cultured cells 
were immuno-stained after each isolation. For electron microscopy, porcine lung epithelial 
cells were cultured on carbon coated cover slips. Confluent cells were fixed using a rapid cold 
fixation method (Wagenaar et al., 1993).
Culture of SK6 cells Epithelial swine kidney (SK6) cells (Kasza et al., 1972) were grown 
in Eagle’s minimal essential medium (EMEM, Gibco) supplemented with 5% FCS, 100 
IU/ml penicillin and 100 µg/ml streptomycin (pen/strep) at 37°C in a 5% CO
2
 atmosphere. 
Viability of cells was assessed by dye exclusion.
Adherence assay Epithelial cells of SK6 and LEC were thawed and seeded in 6-well 
plates in medium with pen/strep at 1.2 × 104 cells/cm2 for LEC (first passage) and at 1.6 
× 104 cells/cm2 for SK6. LEC were used as confluent layers and SK6 cells were used at 
near confluence. The culture medium was replaced by culture medium without antibiotics 
24 h prior to the adherence assay. Before incubation with bacteria, cells were washed 
with three times 3 ml of PBS to remove loose adherent cells and residual antibiotics, and 
fresh culture medium without antibiotics was added. One hundred µl of culture medium 
was tested for the absence of antibiotics by a disc diffusion assay on plate count agar with 
Bacillus staerothermophilus. Cell monolayers were incubated (37°C, 5% CO
2
) with variable 
numbers of bacteria from an overnight culture on agar plates. At various times, non-adherent 
bacteria were removed by washing with four times 3 ml of PBS, and the cells were fixed 
with methanol (10 min, RT) and stained with water-diluted Giemsa stain (Merck). Bacterial 
adherence was scored by counting at least 20 (LEC) or 7 (SK6) randomly selected visual 
fields in an Olympus microscope (100 × objective). This yielded sufficient numbers of cells 
for statistical purposes in both cases. The average number of counted cells per field was 
1.25 for large LEC and 7 for small LEC, and 31.7 for SK6. Adherence was expressed as the 
percentage of cells with adherent bacteria and as the average number of bacteria per cell 
(only cells with adherent bacteria were taken into account). Tests were rejected when B. 
bronchiseptica (positive control) adhered to less than 50% of the cells (8% of the tests) or 
when P. multocida (negative control) adhered to more than 40% of the cells (4% of the tests) 
after 2 h incubation with 108 or 107 colony forming units per ml (CFU/ml).
CHAPTER 3
42 43
ADHERENCE OF A. PLEUROPNEUMONIAE
Effect of LPS on adherence To measure the effect of LPS on adherence, LEC were pre-
incubated with dilutions of LPS isolated from A. pleuropneumoniae strains R1, R3, R7 and 
R8, and from E. coli O111:B4 (Sigma). After 30 min of incubation, A. pleuropneumoniae 
strain R8 was added to the wells and incubated for 2 h as described above.
Statistical analysis Preliminary analyses showed that variances of adherence clearly 
depended on the levels of means. Therefore generalised linear models were used to analyse 
the data. Means of the percentage of cells with adherent bacteria were analysed with a logistic 
link and a variance function proportional to pure binomial variance. Means of the number of 
bacteria per cell were analysed with a logarithmic link and a variance function proportional 
to the square of the mean. In accordance with these models pairwise comparisons between 
means were done at P = 0.05 significance level. All calculations were performed with the 
statistical programming language Genstat 5 (Genstat, 1993).
RESULTS
Characterisation of cultured lung cells Ninety percent of cultured lung cells stained 
positive with anti-cytokeratine specific for epithelial cells. The remaining 10% of the 
lung cells did not stain with anti-vimentin for fibroblasts or anti-macrophage for alveolar 
macrophages. Electron microscopy showed desmosomes between cells, large nuclei with 
little structure and no ciliary structures. Ciliary structures were not seen on freshly isolated 
lung cells either. Based on the reactivity with anti-cytokeratine and the morphology, we 
considered the cultured cells to be lung epithelial cells (LEC). Cultures of LEC contained two 
different cell phenotypes: small and large cells (Fig. 1). Both cell types stained similar in the 
immuno-staining, the small cells were more abundant. Small LEC grew in close contact with 
each other and were approximately 30 µm in diameter. Large LEC were large polymorphic, 
polynucleated flat cells and were approximately 100 µm in diameter. Cultures were confluent 
5 days after seeding at 1.2 × 104 cells/cm2. In all experiments with LEC, data have been 
collected for both small and large cells separately.
Adherence of A. pleuropneumoniae strain R7 to LEC A. pleuropneumoniae strain R7 
produces only one toxin (ApxII) and has low cytotoxic activity. This strain was chosen to 
optimize the conditions for adherence. B. bronchiseptica (positive control) and P. multocida 
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FIG. 1. Adherence of A. pleuropneumoniae strain R7 to large and small LEC in 
culture after an incubation time of 2 h and a bacterial inoculation of 108 CFU/ml 
(40 × objective). Shown is one large LEC surrounded by small LEC. Arrows 
indicate bound bacteria, bar is 100 µm.
(negative control) served to assess the quality of the assay. Variation of incubation time and 
bacterial concentration demonstrated that adherence of A. pleuropneumoniae R7 to LEC was 
time and dose related (Fig. 2 and 3). Adherence reached a plateau after 2 h incubation with 
80−100% cells (Fig. 2) carrying on average seven bacteria (small LEC) and 62 bacteria (large 
LEC). The number of bacteria per small LEC was lower than the number of bacteria per large 
LEC, likely because of the smaller surface of small LEC. Lower bacterial concentrations led 
to decreased percentages of LEC with adherent bacteria (Fig. 3) and to decreased numbers 
of bacteria per small and large LEC (data not shown) after an incubation time of 2 h. At a 
concentration of 108 CFU/ml, strain R7 adhered to 77% of small LEC with nine bacteria per 
cell and to 100% of large LEC with 21 bacteria per cell. The kinetics of adherence for small 
and large LEC were similar. An incubation time of 2 h was chosen as the standard incubation 
time because saturation appeared to be reached at this time point. A bacterial concentration 
of 107 CFU/ml was used in subsequent assays to detect differences between highly adherent 
strains or between treatments.
Adherence of strain R7 to SK6 was also found to be time related (Fig. 2) and was markedly 
lower than adherence to LEC. After 3 h incubation, adherence of A. pleuropneumoniae 
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reference strain of serotype 7 (R7) reached a plateau of 30% cells with adherent bacteria 
(Fig. 2). After 2 h incubation strain R7 adhered to 19% SK6 cells with 1.8 bacteria per cell. 
At a concentration of 108 CFU/ml, adherence of strain R7 to SK6 was markedly lower than 
FIG. 3. Effect of bacterial concentration on adherence of A. pleuropneumoniae 
strain R7 (ê), B. bronchiseptica (T) and P. multocida (t) to small LEC, 
large LEC and SK6 with an incubation time of 2 h. Adherence is expressed as 
percentage of cells with adherent bacteria and the results mean of a three-fold 
(LEC) and a two-fold (SK6) experiment are shown.
FIG. 2. Effect of incubation time on adherence of A. pleuropneumoniae strain 
R7 (ê), B. bronchiseptica (T) and P. multocida (t) to small LEC, large 
LEC and SK6 with a bacterial concentration of 108 CFU/ml. Adherence is 
expressed as percentage of cells with adherent bacteria and the mean results 
of a three-fold (LEC) and a two-fold (SK6) experiment are shown.
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FIG. 4. Adherence of A. pleuropneumoniae strains R1, R3, R7 and R8, B. bronchiseptica 
(Bb) and P. multocida (Pm) to small and large LEC with an incubation time of 2 h. The 
bacterial concentrations ranged from 1.0 to 1.7 × 107 CFU/ml. The mean results and 
standard error of the mean (S.E.M.) of a six-fold experiment are shown.
adherence to LEC (Fig. 3). Lower concentrations led to decreased percentages of SK6 cells 
with adherent bacteria. Together, these data indicate that adherence of A. pleuropneumoniae 
to LEC cells was much more rapid and more effcient than to the swine kidney cell line.
Incubation of LEC with A. pleuropneumoniae reference strains R1, R3, R7 and R8 (108 
CFU/ml, 2 h of incubation) did not result in significant changes in cell number or viability. 
Similar experiments with SK6 cells yielded similar results except that with strain R1 a 
reduction in cell number (11% of control, P < 0.05) was observed.
Adherence of A. pleuropneumoniae strains R1, R3, R7 and R8 Possible variability 
between A. pleuropneumoniae strains with respect to adherence was assessed by comparing 
the adherence of the reference strains R1, R3, R7 and R8 (Fig. 4). Strain R3 adhered to more 
LEC of both phenotypes and with more bacteria per cell than strains R1, R7 and R8 (P < 
0.05). Strains R7 and R8 adhered to more LEC of both phenotypes than strain R1 (P < 0.05) 
and strain R7 adhered with more bacteria per cell to large LEC than strain R1 (P < 0.05).
Role of LPS in adherence of A. pleuropneumoniae LPS has previously been implicated 
to mediate adherence of A. pleuropneumoniae to tracheal epithelial cells (Belanger et al., 
1990; Paradis et al., 1994). To test whether LPS is involved in adherence to lower respiratory 
tract epithelium, three different A. pleuropneumoniae LPS transposon mutants and their 
parent strain were tested for their adherence to LEC (Fig. 5). Mutant #5.1 which produces 
a modified core lipid A, adhered similarly as the parent. Mutants #15.1 and #24.1, which 
lacked O-antigen, adhered to more small LEC and with more bacteria per cell to large LEC 
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(P < 0.05) compared to the parent strain (Fig. 5), suggesting that the O-antigen was not 
required for adherence in our model. To further corroborate this finding we evaluated the 
ability of purified LPS to inhibit adherence. Adherence of A. pleuropneumoniae strain R8 
to LEC was unaltered (P < 0.05) when LEC were pre-incubated with LPS isolated from A. 
pleuropneumoniae strains R3 and R8 (Fig. 6). LPS from strains R1 and R7 had no significant 
effect on adherence of R8 either (data not shown).
FIG. 6. Adherence of A. pleuropneumoniae strain R8 to small and large LEC in the presence 
of LPS from strains R3 and R8. An incubation time of 2 h and a bacterial concentration of 4.4 
× 107 CFU/ml were used. White bars represent LPS from strain R3 and shaded bars represent 
LPS from strain R8. An asterisk indicates that a result differs significantly from incubations 
without LPS. The mean results of a three-fold experiment are shown.
FIG. 5. Adherence of LPS transposon mutants of A. pleuropneumoniae serotype 1 and their 
parent strain to small and large LEC. An incubation time of 2 h and a bacterial concentration of 5 
× 107 CFU/ml were used. White bars represent small LEC and shaded bars represent large LEC. 
An asterisk indicates that a result differs significantly from that of the parent. The mean results 
and S.E.M. of a four-fold experiment are shown.
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DISCUSSION
We have developed an adherence model for A. pleuropneumoniae using primary cultures 
of LEC. We tested the effect of incubation time and bacterial concentration on adherence of 
A. pleuropneumoniae. A. pleuropneumoniae reference strain R7 adhered at higher levels to 
LEC than to SK6 after shorter incubation times and at lower bacterial concentrations. This 
indicates that A. pleuropneumoniae has a higher affinity for LEC than for SK6 and stresses 
the importance of using organ specific cells in studying adherence of A. pleuropneumoniae. 
The highest adherence to LEC was observed for strain R3 and the lowest for strain R1. The 
cause of the differences between these A. pleuropneumoniae strains is unkown.
It has been demonstrated that bacteria adhere better to viable cells than to fixed cells and 
that adherence may involve a modulation of the host cell that requires de novo protein synthesis 
(Su et al., 1998). Because an active role of host cells in adherence of A. pleuropneumoniae 
cannot be excluded, we decided to use viable cells for our adherence model. Previously, 
adherence of A. pleuropneumoniae serotypes 1, 2, 5 and 7 has been shown to frozen lung- and 
trachea sections (Jacques et al., 1991; Paradis et al., 1994; Paradis et al., 1999) or methanol-
fixed alveolar epithelial cells (Haesebrouck et al., 1996; Van Overbeke et al., 2000). Because 
living cells are sensitive to Apx toxins (Van Leengoed et al., 1989; Serebrin et al., 1991; 
Idris et al., 1992; Jansen et al., 1995) we tested the effect of A. pleuropneumoniae on cell-
number and viability of cultured LEC and SK6 cells. The number and viability of cultured 
LEC were not affected by incubations with A. pleuropneumoniae strains R1, R3, R7 and 
R8. The number of SK6 cells was reduced by A. pleuropneumoniae strain R1 only, no effect 
was observed with strains R3, R7 and R8. From these results we conclude that this model is 
suitable to test adherence of A. pleuropneumoniae and that it can be used to identify factors 
that are involved in adherence.
A wide variety of adhesins is displayed by Gram-negative bacteria. Adhesins are 
responsible for recognizing and binding to specific receptors on the host cell. Various proteins 
and LPS have been identified that act as adhesins. In many cases, proteins are assembled 
into hair-like appendages called fimbriae. Fimbriae are produced by related species like A. 
actinomycetemcomitans (Kachlany et al., 2001), Haemophilus influenzae (Van Ham et al., 
1995) and P. multocida (Doughty et al., 2000). Up till now, little is known about fimbriae 
of A. pleuropneumoniae. The presence of fimbriae has been observed (Utrera and Pijoan, 
1991; Dom et al., 1994) and Zhang et al. (2000) isolated and identified type IV fimbriae of 
A. pleuropneumoniae. However, the role of fimbriae in adherence of A. pleuropneumoniae 
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to LEC is unknown.
Adherence of A. pleuropneumoniae to the respiratory tract has been reported to be 
related to LPS (Belanger et al., 1990; Paradis et al., 1994). Homologous LPS inhibited 
adherence to tracheal rings (89%−99%) (Belanger et al., 1990) and frozen lung sections 
(70−80%) (Paradis et al., 1994). The inhibition of adherence to frozen lung sections was 
found to be caused by the polysaccharide moiety of LPS comprising the O-chain and core 
oligosaccharide. To examine the role of LPS and particularly the O-antigen and the core 
region of LPS in adherence, three A. pleuropneumoniae LPS transposon mutants and their 
parent strain were tested for their ability to adhere to LEC. In accordance with data of Rioux 
et al. (1999), the O-antigen mutants showed increased binding efficiencies indicating that 
the O-antigen masks adhesins. In contrast to data of  Rioux et al. (1999) no effect of core 
region alteration was observed on adherence to LEC. This indicates that LPS and particularly 
the O-antigen is not essential in adherence to LEC. This conclusion was confirmed by the 
finding that adherence of A. pleuropneumoniae could not significantly be inhibited by LPS. 
Apparently different adhesins are involved in adherence of A. pleuropneumoniae to living 
LEC or frozen trachea.
Here we have shown that differences between mutants and between treatments can be 
tested in this adherence model using living LEC. In future studies this model can be used to 
identify possible adhesins.
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ABSTRACT
The type IV fimbrial gene cluster of Actinobacillus pleuropneumoniae serotype 1 was 
cloned and characterised. The cluster was identified via screening of a genomic library with a 
part of the fimbrial subunit gene apfA obtained by touch down PCR with degenerate primers. 
Sequence analysis revealed that the cluster consisted of four genes that were designated as 
apfA, apfB, apfC and apfD based on their similarity with type IV fimbrial genes in other 
Pasteurellaceae. Sequencing of the apfA gene of forty-two strains of A. pleuropneumoniae 
showed a characteristic alanine residue at the position -1 from the cleavage site in ApfA which 
is different from the consensus glycine at this position in type IV subunits of other species. 
Southern blot hybridisation revealed that only a single copy of apfA is present in the A. 
pleuropneumoniae genome. Western blot analysis with an ApfA specific antiserum failed to 
demonstrate expression of the apfA gene for a number of A. pleuropneumoniae strains grown 
in different media. ApfA was detected when the apfA gene or the entire fimbriae cluster were 
placed under an active promoter in an expression vector. Electron microscopy demonstrated 
that transfer of the expression vector carrying the fimbrial operon into A. pleuropneumoniae 
resulted in fimbriae protruding from the bacterial surface despite the presence of the Ala 
residue at (-1) relative to ApfA cleavage site.
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INTRODUCTION
Actinobacillus pleuropneumoniae causes porcine pleuropneumonia, a disease that 
is distributed world-wide and causes severe economic losses to the pig rearing industry 
(Barnum, 1990; Nicolet, 1992). Based on differences in capsule composition, 15 serotypes 
of A. pleuropneumoniae have been identified (Blackall et al., 2002; Schaller et al., 2001). All 
serotypes cause severe disease and death in pigs. The molecular pathogenesis of the infection 
is not completely understood. Several virulence factors have been described that enable the 
bacterium to survive in vivo (Haesebrouck et al., 1997). Major virulence factors include the 
polysaccharide capsule (Inzana et al., 1993; Rosendal and MacInnes, 1990; Ward and Inzana, 
1994), several toxins (Frey, 1995; Kamp et al., 1997), and lipopolysaccharide (LPS) (Udeze 
et al., 1987). Capsule has been shown to protect against killing by antibody and complement, 
and against phagocytosis by polymorphonuclear leucocytes (Inzana et al., 1988; Ward and 
Inzana, 1994). The toxins have been shown to be involved in the development of lesions 
(Kamp et al., 1997). The bacterial lipopolysaccharide (LPS) has been shown to play a 
role in the adherence to mucus, tracheal rings and frozen lung sections (Belanger et al., 
1990; Belanger et al., 1994; Paradis et al., 1994). Several reports suggest that besides LPS 
additional adhesins may facilitate bacterial attachment to the mucosal surface. For adherence 
to alveolar epithelial cells both LPS and proteins have been shown to be required (Van 
Overbeke et al., 2002), while adherence to primary cultures of lung epithelial cells appears 
to be an LPS-independent event (Boekema et al., 2003). These data indicate the presence of 
other thus far unidentified adhesins at the bacterial cell surface.
Many bacterial pathogens carry fimbriae that mediate adherence of bacteria to host 
cells (Strom and Lory, 1993). Fimbriae or pili are filamentous polymeric structures that 
protrude from the cell surface (Wu and Fives-Taylor, 2001). Recently, fimbriae have been 
isolated from A. pleuropneumoniae. N-terminal amino acid sequencing of the major subunit 
indicated that the fimbriae belong to the type IV family of fimbriae (Zhang et al., 2000). Type 
IV fimbriae form an unique class of multifunctional fimbriae defined by shared structural 
features and a conserved biogenesis pathway. They are found in extremely diverse groups of 
Gram-negative species (Strom and Lory, 1993) and can be involved in natural competence 
(Kennan et al., 2001; Meier et al., 2002; Wolfgang et al., 1998), adherence (Hahn, 1997; 
Nassif et al., 1997; Paranjpye et al., 1998; Stone and Abu Kwaik, 1998; Strom and Lory, 
1993), protein export (Fullner and Mekalanos, 1999; Hobbs and Mattick, 1993; Kennan et 
al., 2001; Pepe et al., 1996; Rossier and Cianciotto, 2001) and twitching motility (Mattick, 
CHAPTER 4
56 57
TYPE IV FIMBRIAE IN A. PLEUROPNEUMONIAE
2002). The fimbriae are composed of subunits ±15−20 kDa in mass which are exported 
from the cell and polymerised to form the fimbrial strand. Assembly of fimbriae requires the 
processing of a hydrophilic leader peptide at a consensus cleavage site by a type IV prepilin 
peptidase during pilin secretion.
In the present study, we took advantage of the conservation of type IV subunits and 
cloned and characterised the type IV fimbriae operon of A. pleuropneumoniae serotype 1. 
The operon was found to contain four type IV fimbriae-like genes. Expression of fimbriae 
subunits and of intact fimbriae in A. pleuropneumoniae was established when the operon was 
cloned on a plasmid behind a constitutive promoter. 
MATERIALS AND METHODS
Bacterial strains, growth conditions and plasmids Strains and plasmids used in this 
study are listed in Table 1. A. pleuropneumoniae strains were grown on sheep blood agar 
(SB) plates containing 0.1% NAD (Calbiochem, La Jolla, California, USA) or on brain heart 
infusion (BHI, Gibco BRL, Paisley, UK) medium containing 0.008% NAD (BHI+NAD) 
with or without 1.5% Bacto Agar (Becton Dickinson., Alphen a/d Rijn, The Netherlands). 
To study fimbriae expression, A. pleuropneumoniae was grown on Luria-Bertani (LB) 
agar plates containing 0.008% NAD (LB+NAD) or in 5 ml of chemically defined medium 
(CDM, Herriott et al., 1970) in air, in CDM under micro-aerophilic conditions (composition 
6% O
2
, 7% CO
2
, 7% H
2
 and 80% N
2
 was obtained with an Anoxomat WS8000 (Mart ® 
Microbiology B.V., Lichtenvoorde, The Netherlands)), in tryptic soy broth (TSB, Biotrading 
Benelux B.V., Mijdrecht, The Netherlands) + 0.008% NAD or in LB medium + 0.008% 
NAD. A. actinomycetemcomitans was grown on SB plates or in Todd Hewitt broth (code 
CM 189; Oxoid Ltd., Inc., Columbia, Maryland, USA). P. multocida strains were grown on 
SB plates and H. influenzae strains were grown on columbia base agar plates supplemented 
with 5% heated sheep blood. All E. coli strains were routinely grown in LB with or without 
1.5% Bacto Agar (Becton Dickinson). When appropriate, ampicillin was added to the growth 
medium at a concentration of 100 µg/ml (E. coli) or 5 µg/ml (A. pleuropneumoniae). E. coli 
M15 (pREP4) was grown in the presence of 25 µg/ml kanamycin. Bacteria were grown at 
37°C, unless indicated otherwise.
DNA transformation For use in electro-transformation, A. pleuropneumoniae reference 
strain S4074 (serotype 1) was grown in 5 ml of TSB with 0.008% NAD (TSB+NAD) at 
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TABLE 1. Bacterial strains and plasmids used
1A. A. pleuropneumoniae strains
Serotypea Strain Source Serotype Strain Source
1 S4074 Reference 3 126023-3 ID-Lelystad
2 1536 Reference 5 J45 Inzanac
3 1421 Reference 6 125739 ID-Lelystad
4 M62 Reference 7 2827 ID-Lelystad
5a K17 Reference 7 25535-2578 ID-Lelystad
5b L20 Reference 7 HS30 Blackall
6 Femø Reference 7 212:89-32159 Hilbinkd
7 WF83 Reference 7 22:91-895 Hilbink
8 405 Reference 7 126398-165 ID-Lelystad
9 CVI13261 Reference 8 20044 ID-Lelystad
10 D13039 Reference 8 896 ID-Lelystad
11 56153 Reference 9 HS17 Blackall
12 8329 Reference 9 125943-191 ID-Lelystad
1a N273 ID-Lelystad 10 3177/89 Nielsene
2a N282 ID-Lelystad 11 117559-1 ID-Lelystad
1 HS25 Blackallb 11 111290 ID-Lelystad
1 HS57 Blackall 11 20492 ID-Lelystad
2 126023-1 ID-Lelystad 11 126219-2 ID-Lelystad
3 117559-5 ID-Lelystad 12 6807/90 Nielsen
3 16169 ID-Lelystad 2a 118126G ID-Lelystad
3 HS77 Blackall 2a 118126K ID-Lelystad
aAll listed strains  are of biotype 1, except strains N273, N282, 118126G and 118126K (biotype 2)
bP. Blackall, Animal Research Institute, Brisbane, Australia
cJ. Inzana, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA
dF. Hilbink, Central Animal Health Laboratory, Upper Hutt, New Zealand
eR. Nielsen, State Veterinary Serum Laboratory, Copenhagen, Denmark
37°C with shaking at 120 rpm. After overnight growth, the culture was diluted ten-fold in 
TSB+NAD and incubated for 90 min at 37°C with shaking. Then, the bacteria were collected 
by centrifugation (5,500 × g, 10 min, 4°C), washed with 25 ml of chilled 274 mM sucrose, 
15% glycerol, and resuspended in 274 mM sucrose, 15% glycerol to an OD
600
 of 6.0. Fifty 
microliters of this cell suspension (which was kept on ice) was mixed with plasmid DNA (1 
µg) and transferred to a prechilled electroporation cuvette (Bio-Rad, Richmond, California, 
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TABLE 1 Continued
1B. Other strains
Strain Relevant characteristics Reference or source
Actinobacillus 
actinomycetemcomitans
Positive for type IV fimbriae ATCC 33384
Pasteurella multocida 
subspecies multocida Carter 
serotype D
Negative for type IV fimbriae NCTC 10325
P. multocida subspecies 
multocida Carter serotype A
Positive for type IV fimbriae NCTC 10322
Haemophilus influenzae Rd Positive for type IV fimbriae Van Ham, RIVM, Bilthoven, 
The Netherlands
H. influenzae AM30 Negative for type IV fimbriae (Van Ham et al., 1995)
Escherichia coli DH5αF’ Library of partially Sau3AI 
digested DNA fragments of A. 
pleuropneumoniae strain AP76 of 
serotype 7 in plasmids pGH432 and 
pGH433
Gerald F. Gerlach, 
Tierärtzliche Hochschule, 
Hannover, Germany (Baltes 
et al., 2003)
E. coli XL2-blue Used for plasmid construction Stratagene, La Jolla, 
California, USA
E. coli M15 (pREP4) Used for analysis of expression 
vectors
Westburg, Leusden, The 
Netherlands
USA) with an electrode distance of 2 mm. Electrical charges (2,500 V, capacitance 25 µF, 
parallel resistor 200 Ohm) were delivered to ice-cold samples using a Gene-pulser (Bio-
Rad). Immediately after the electrical charge 900 µl of SOC medium (Sambrook et al., 
1989) supplemented with 0.008% NAD was added and the cells were allowed to recover at 
37°C for 3 hours with shaking. The cell suspension was plated onto BHI+NAD agar plates 
containing 5 µg/ml ampicillin (BHI+NAD+Amp). Transformants were grown overnight in 5 
ml BHI+NAD+Amp and stored at -70°C in 50% glycerol in BHI. Transformation to E. coli 
was done according to the instructions supplied by the manufacturer.
PCR reactions Oligonucleotides used for PCR and DNA sequencing were obtained from 
Isogen Biosciences BV (Maarsen, The Netherlands) or Gibco. Relevant oligonucleotides 
are listed in Table 2. Touch down PCR was carried out by using the AmpliTaq® DNA 
polymerase kit reagents (Roche Molecular Systems, Inc., Branchburg, New Jersey, USA) 
according to the supplied protocol using primers 1024 and 1025. Each 50 µl PCR reaction 
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contained 50 ng of template DNA, 15 pmol of (each) primer, 200 µM of deoxynucleoside 
triphosphate mix, 1× PCR buffer and 1.25 units of enzyme. Each sample was amplified using 
the following conditions: 10 min at 94°C, 10 cycles of 15 s at 94°C, 15 s at 55°C - 0.5°C per 
cycle and 10 s at 72°C, followed by 30 cycles of 15 s at 94°C, 15 s at 50°C and 1 min at 72°C, 
followed by 7 min at 72°C.
Amplification of the complete fimbriae operon was done by using the ExpandTM High 
Fidelity kit (Roche) according to the supplied protocol using primers 25 and 26. Each 50 
µl PCR reaction contained 50 of ng template DNA, 15 pmol of (each) primer, 200 µM of 
deoxynucleoside triphosphate mix, 1× buffer and 2.6 units of enzyme mix. Each sample was 
amplified using the following conditions: 2 min at 95°C, 10 cycles of 20 s at 94°C, 30 s at 
55°C and 270 s at 68°C, followed by 20 cycles of 20 s at 94°C, 30 s at 55°C and 270 s + 5 s 
TABLE 1 Continued
1C. Plasmids Relevant characteristics Reference or source
pQE30 Expression vector Westburg
pQE-ApfA 0.5 kb BamHI-SphI fragment containing the A. 
pleuropneumoniae apfA lacking part of the signal 
peptide in frame with N-terminal HIS-tag in pQE30
This study
pGEM7 Used for cloning Promega
pGH432 & 
pGH433
Vectors used for construction of a library of 
partially Sau3AI digested DNA fragments of A. 
pleuropneumoniae strain AP76 of serotype 7
Gerald F. Gerlach (Baltes et 
al., 2003)
pUC18 Used for cloning Gibco
pSD2 Active SD2 promoter of A. pleuropneumoniae 
serotype 1 in a promoter-trap vector
Martha Mulks, Michigan 
State University, East 
Lansing, Michigan, USA 
(Doree and Mulks, 2001)
pUC-
ApfABCD
3.9 kb XbaI-BamHI fragment containing the A. 
pleuropneumoniae apfABCD operon including the 
RBS but lacking the promoter in pUC18
This study
pUC-SD2-
ApfABCD
SD2 promoter upstream of the fimbriae operon in 
pUC-ApfABCD
This study
pGZRS19 E. coli-A. pleuropneumoniae shuttle vector Susan West, University 
of Wisconsin-Madison, 
Madison, Wisconsin, USA 
(West et al., 1995)
pGZRS-F1 Fimbriae operon downstream of SD2 promoter in 
pGZRS19
This study
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per cycle at 68°C, followed by 10 min at 72°C.
Standard PCR was carried out by using the Takara ExTaqTM kit reagents (Takara 
Shuzo Co., Ltd., Otsu, Shiga, Japan) according to the supplied protocol. Each 50 µl PCR 
reaction contained 50 of ng template DNA, 15 of pmol primer, 200 µM of deoxynucleoside 
triphosphate mix, 1× PCR buffer and 1.25 units of enzyme. Each sample was amplified using 
the following conditions: 10 min at 94°C, 30 cycles of 15 s at 94°C, 30 s at 60°C and 30 s at 
72°C, followed by 7 min at 72°C. All PCR reactions were performed on a Primus 96 (MWG 
Biotech AG, Ebersberg, Germany).
TABLE 2. Oligonucleotides used in this study
Oligo-
nucleotide
Location 
(nt)a
Use Sequence (5’ - 3’)b
1024 1167-1198 Touch down PCR on 
fimbrial subunit
AAAAAAGGGTTTACATTAATCG
1025 1379-1354 Touch down PCR on 
fimbrial subunit
GCTIIAATICCITTTTGTCCICCII-TAC
FwG 1742-1768c Insert PCR on pGH432 
& pGH433
CGGCCAAGCTTACTCCCCATC-CCC
RevG 1947-1921c Insert PCR on pGH432 
& pGH433
CCACTCCCTGCCTCTGTCATCA-CG
8 135-156 Sequence analysis of 
cleavage site
TGTTCGGTCATGGCAAATACGC
9 BamHI 1155-1175 Cloning of apfA CGGGATCCCGTATTCGACCGCT-
TACTAACGCG
10 SphI 1642-1664 Cloning of apfA ACATGCATGCATGTGCCACTGT-
TCCTCGGAAATCCGG
25 XbaI 1037-1059 Cloning ofapfABCD GCTCTAGAGCGATACGGATCG-
CAGAAGTCGG
26 BamHI 4882-4902 Cloning of apfABCD CGGGATCCCGCCGATTCCACC-
GGTTAAACCG
aAccording to the operon sequence of A. pleuropneumoniae strain AP76 of serotype 7 determined for 
this paper
bI : inosine. Inosine was incorporated to reduce specificity. Underlined nucleotides are not exact 
matches to the sequence and were altered to add restriction enzyme sites
cLocation in plasmids pGH432 and pGH433, used for sequence analysis of inserts of A. 
pleuropneumoniae genomic DNA
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DNA manipulations, Southern blotting and hybridisation Plasmid DNA was isolated 
by using the Miniprep or Midiprep Wizard kit (Promega Corporation, Madison, Wisconsin, 
USA). Genomic DNA was isolated as described by Sambrook et al. (1989). DNA ligations 
were done by using the rapid ligation kit (Roche Diagnostics GmbH, Roche Molecular 
Biochemicals, Mannheim, Germany). For use in Southern or spotblot hybridisation, PCR 
products were labeled with [α-32P]CTP via random-primed labeling (Boehringer Mannheim). 
For spotblotting, 3 µl plasmid DNA or 3 µl culture was spotted on Genescreen Plus (NENTM 
Life Science Products, Boston, Massachusetts, USA), denatured with 0.4 M NaOH, 1 M 
NaCl (two times 5 min), and neutralised in 2× SSC (composition of 1× SSC: 150 mM NaCl, 
25 mM sodium citrate). For Southern blotting, approximately 20 µg of bacterial genomic 
DNA was digested with EcoRI, subjected to electrophoresis in a 0.8% agarose gel, and 
transferred to Genescreen Plus by standard procedures (Sambrook et al., 1989). Radioactive 
labeled amplicons were boiled for 10 min, chilled in ice, and used as probes. Blots were 
incubated with the labeled probes for 16 h at 65°C in hybridisation solution (342 mM 
Na
2
HPO
4
, 158 mM NaH
2
PO
4
, 1 mM EDTA, 7% (wt/vol) sodium dodecyl sulfate (SDS)). 
The membranes were washed twice (30 min, 65°C) with washing solution (27 mM Na
2
HPO
4
, 
13 mM NaH
2
PO
4
, 1 mM EDTA) containing 5% SDS, and twice (30 min, 65°C) with the same 
solution containing 1% SDS.
Cloning To construct an ApfA expression plasmid, primers 9 and 10 (Table 2, Fig. 
1) were used to amplify the apfA gene. The resulting PCR product was cloned in pQE30 
with BamHI and SphI generating pQE-ApfA. pQE-ApfA was transformed to E. coli M15 
(pREP4). Expression was induced by the addition of 1 mM IPTG.
The entire fimbriae operon of A. pleuropneumoniae serotype 1 containing the putative 
ribosomal binding sequence (RBS) but lacking its own putative promoter sequence was 
amplified with primers 25 and 26 (Table 2, Fig. 1) and the High Fidelity kit. The resulting 
PCR product was cloned in pUC18 with XbaI and BamHI generating pUC-ApfABCD. An 
EcoRI fragment from pSD2 containing the transcription terminator T4 and constitutive 
A. pleuropneumoniae promoter SD2 was subcloned in pGEM7 and a 600 bp fragment 
containing T4/SD2 was cloned with HindIII and XbaI upstream of the fimbriae operon in 
pUC-ApfABCD generating pUC-SD2-ApfABCD. The fragment containing T4/SD2 and the 
fimbriae operon was subsequently cloned in pGZRS19 with HindIII and BamHI generating 
pGZRS-F1. pGZRS19 and pGZRS-F1 were transformed to E. coli XL2 as well as to A. 
pleuropneumoniae S4074. Sequence analysis was performed on inserts of pQE-ApfA and 
pUC-ApfABCD.
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DNA sequencing and analysis DNA sequences were determined by using the Dye 
terminator cycle sequencing ready reaction kit (PE Biosystems, Warrington, UK) in an 
ABI 373A DNA sequencer (Applied Biosystems, Forster City, California, USA). Reactions 
contained 500 ng of template plasmid DNA or 20 ng PCR product, 8 µl of reaction mix, and 
3.2 pmol of primer in a 20 µl volume. Alternatively, DNA sequences were determined by 
Plant Research International (Wageningen, The Netherlands) by using the BigDyeTerminator 
mix (version 2.0, Applied Biosystems). Reactions contained 500 ng of template plasmid 
DNA, 4 µl of reaction mix, and 10 pmol of primer in a 10 µl volume. Cycle sequencing 
reactions were performed on a Primus 96 (MWG Biotech). In all cases, both strands were 
sequenced. Primers FwG and RevG (Table 2) were used for sequence analysis of inserts 
in plasmids pGH432 and pGH433. Sequence analysis was performed using the DNAstar 
software package (DNAstar Inc., Madison, Wisconsin, USA). To search for homologies, 
the nucleotide and amino acid sequences were compared with sequences in the GenBank 
databases by using BLAST (Altschul et al., 1990).
SDS-PAGE and Western blot analysis Production of fimbriae subunits was analysed by 
SDS-PAGE (17.5% polyacrylamide) and Western blotting. Blots were immunostained with 
6×HIS monoclonal antibody (anti-HIS, Clontech Laboratories, Palo Alto, California, USA) 
or polyclonal anti-fimbriae peptide serum (Eurogentec, Seraing, Belgium). The anti-fimbriae 
peptide serum was raised in mice against a short synthetic peptide with amino acid sequence 
CSGGQNGVRKMTELR from ApfA (Eurogentec).
Electron microscopy Cultures were examined for the presence of fimbriae by negative 
staining. Bacteria were absorbed on carbon-coated collodion nickel grids from agar plates or 
suspensions. The grids were then floated three times for 5 s on a solution of 1% methylamine 
tungstate (Bio-Rad). After staining, the specimen were viewed with a Philips CM10.
Adherence assay The isolation and culture of porcine lung epithelial cells (LEC) 
were perfomed as described (Boekema et al., 2003). Cell monolayers were incubated with 
approximately 108 CFU/ml bacteria from an overnight culture (37°C, 5% CO
2
) supplemented 
with 5 µg/ml ampicillin. After 2 hours, non-adherent bacteria were removed by washing 
with four times with 3 ml of PBS, and the cells were fixed with methanol (10 min, RT) 
and stained with water-diluted Giemsa stain (Merck Diagnostica, Darmstadt, Germany). 
Bacterial adherence was scored by counting at least 20 randomly selected visual fields in an 
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Olympus microscope (100 × objective). This yielded sufficient numbers of cells for statistical 
purposes. Separate scores were obtained for the large and small cell phenotypes present in the 
LEC cultures. The average number of counted cells per field was 1.1 for large LEC and 11.4 
for small LEC. Adherence was expressed as the percentage of cells with adherent bacteria 
and as the average number of bacteria per cell (only cells with adherent bacteria were taken 
into account).
Nucleotide sequence accession numbers The nucleotide sequences containing the type 
IV fimbriae operon of A. pleuropneumoniae serotype 1 (S4074) and serotype 7 are available 
at GenBank under accession no. AY235718 and AY235719, respectively.
RESULTS
Cloning of the A. pleuropneumoniae fimbrial gene cluster As a strategy to identify 
genes involved in fimbriae production in A. pleuropneumoniae, we amplified part of the major 
subunit gene with primers (1024 and 1025, Table 2). The primers were designed on the basis 
of the conserved fimbriae subunit sequence in H. influenzae and A. actinomycetemcomitans 
and the previously determined N-terminal amino acid sequence of an A. pleuropneumoniae 
subunit (Zhang et al., 2000). Inosines were incorporated at seven positions in primer 1025 
to reduce its specificity. Touch down PCR with these primers on genomic DNA from A. 
actinomycetemcomitans, H. influenzae Rd, H. influenzae AM30, P. multocida type D, P. 
multocida type A and A. pleuropneumoniae reference strains S4074, 1536 and WF83 (Table 
1) yielded bands of the expected size (220 bp) at annealing temperatures ranging from 
55−50°C for H. influenzae Rd and A. actinomycetemcomitans, 45−40°C for P. multocida 
type A, and 40−35°C for the three A. pleuropneumoniae strains. DNA sequencing and 
subsequent analysis of the PCR fragments obtained with A. pleuropneumoniae DNA 
revealed 55% similarity at the amino acid level with the type IV fimbriae subunits of A. 
actinomycetemcomitans, H. influenzae Rd and P. multocida.
In order to obtain the entire subunit gene (designated as apfA) and possible flanking 
fimbrial genes, a DNA library of A. pleuropneumoniae strain AP76 of serotype 7 was 
hybridised with the obtained apfA PCR fragments. Hybridising clones were collected and the 
entire DNA sequence of the inserts was determined. This procedure yielded a 5,303 bp DNA 
region that contained four complete and two partial open reading frames (ORFs) (Fig. 1).
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Properties of the major fimbrial subunit gene, apfA Sequence analysis indicated 
that the first complete ORF of the identified region was the apfA gene. The gene was 444 
bp in length and was predicted to encode a 15.9 kDa protein (Fig. 2). The putative protein 
was 81% similar to the fimbriae subunits of H. influenzae, A. actinomycetemcomitans, P. 
multocida (Fig. 2) and Haemophilus somnus and identical to the putative ApfA protein of A. 
pleuropneumoniae serotype 2 listed in the database (GenBank accession number AF302997). 
The amino terminus of ApfA appeared to contain a short positively charged signal peptide 
of 13 amino acids in length (Fig. 2) that was similar to the predicted signal peptides of the 
subunit proteins of H. influenzae and P. multocida (Doughty et al., 2000; Fleischmann et 
al., 1995) but 6 residues longer than the signal peptides of several other subunit proteins 
(Strom and Lory, 1993). The deduced protein sequence following this region corresponded 
to the amino acid sequence determined previously for the mature subunit (Zhang et al., 
2000). This region was hydrophobic and shared similarities with similar subunit sequences 
in other Gram-negative bacteria except for a remarkable Ala residue at position -1 relative to 
the cleavage site (Strom and Lory, 1993) (Fig. 2). Most known type IV prepilin-like leader 
sequences contain a glycine at this position (Strom and Lory, 1993) (Fig. 2). PCR with 
primers 8 and 10 (Fig. 1) and sequence analysis on fourty-two strains (Table 1A) including 
HS25, a strain which has been reported to produce fimbriae (Zhang et al., 2000) confirmed 
the Ala residue at position -1 as an intrinsic trait of the A. pleuropneumonia subunit gene 
(data not shown). A stop codon instead of a glycine was found at residue 68 of the fimbriae 
subunit in A. pleuropneumoniae reference strain of serotype 7 (WF83). Further analysis of 
apfA indicated that the putative ApfA protein contained two pairs of cysteine residues as 
was reported for H. influenzae, A. actinomycetemcomitans and P. multocida (Doughty et al., 
2000; Fleischmann et al., 1995; unfinished genome of A. actinomycetemcomitans available 
through GenBank). The first pair of cysteines was located at the amino acid positions 63 and 
FIG. 1. Arrangement of the type IV fimbriae operon in A. pleuropneumoniae. The region between 
accolades was completely sequenced. Open arrows represent type IV fimbriae genes, filled arrows 
represent genes that are not involved in fimbriae biogenesis. Small black arrows with numbers indicate 
the positions of primers (Table 2).
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73 and the second pair at the residues 132 and 145.
Organisation and characterisation of the remaining of the fimbrial gene cluster 
Seventeen bp downstream of the A. pleuropneumoniae apfA gene, a second ORF (designated 
as apfB) was identified. This gene was predicted to encode a 53.0 kDa protein that showed 
78% similarity to the PilB analogues of A. actinomycetemcomitans, P. multocida, H. somnus 
and H. influenzae involved in fimbriae assembly (Turner et al., 1993). The protein possessed 
the highly conserved Walker sequence, an ATP binding motif found in PilB like proteins 
(Turner et al., 1993). Downstream of the A. pleuropneumoniae apfB gene, a third ORF 
(designated as apfC) was present that overlapped apfB by 17 bp. This ORF was predicted 
to encode a 45.6 kDa protein with 60% similarity to PilC analogues of H. influenzae, A. 
actinomycetemcomitans, H. somnus and P. multocida. Based on mutational analysis, PilC is 
thought to be required for fimbriae biogenesis (Koga et al., 1993; Pepe et al., 1996; Tonjum et 
al., 1995). At 26 bp downstream of the A. pleuropneumoniae apfC, a fourth ORF (designated 
as apfD) was identified that was predicted to encode a 24.6 kDa protein with 45% similarity 
to PilD of A. actinomycetemcomitans but with very low similarity to P. multocida and H. 
influenzae sequences. apfD putatively encodes a prepilin peptidase that cleaves the positively 
charged N-terminal signal peptide of ApfA and methylates the exposed phenylalanine residue 
(Lory and Strom, 1997; Strom et al., 1993b).
Analysis of the ORFs flanking apfA-apfD revealed a partial ORF at 181 bp upstream of 
apfA on the opposite strand that showed similarity to radA. This gene is involved in DNA 
repair and has no known relation with fimbriae biogenesis (Song and Sargentini, 1996). 
Downstream of apfD, a partial ORF was found that showed similarity to yacE. This gene 
encodes the enzyme dephosphocoenzyme A kinase that catalyses the final step in coenzyme 
A biosynthesis, the phosphorylation of the 3’-hydroxy group of the ribose sugar moiety 
(Mishra et al., 2001). This gene also has no known relation with fimbriae biogenesis.
Analysis of the intergenic sequences indicated that the apfA gene was preceded at six bp 
upstream of the putative start codon by the sequence AGGAGA that resembled the AGGAGG 
consensus RBS for A. pleuropneumoniae (Doree and Mulks, 2001). A putative promoter with 
the sequence TTGAC (-35) and TATAAT (-10) with a spacing of 19 bp was identified at 180 
bp from the ATG start codon. This promoter structure is similar to the consensus promoter 
structure TT(G/A)AA (-35) and TATAAT (-10) in A. pleuropneumoniae (Doree and Mulks, 
2001). None of the different fimbriae genes was followed by a transcriptional terminator. 
This in conjunction with the spacing of the apfA-apfD genes suggests that the genes are 
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FIG. 3. Southern blot of EcoRI digested 
genomic DNA of A. pleuropneumoniae, 
probed with a PCR product 
containing apfA. Genomic DNA of A. 
pleuropneumoniae reference strains of 
serotype 1 (S4074, lane 1) and serotype 
7 (WF83, lane 2) and field isolates HS25 
(lane 3) and HS77 (lane 4) was used. Sizes 
in kilobases are indicated on the right.
arranged in an operon and may be co-transcribed. A schematic representation of the fimbriae 
operon in A. pleuropneumoniae is given in Fig. 1.
A. pleuropneumoniae carries a single type IV fimbriae operon To ascertain the presence 
of a single copy of apfA in the A. pleuropneumoniae genome, a Southern blot hybridization 
was performed. Genomic DNA, isolated 
from A. pleuropneumoniae reference strains 
of serotypes 1 and 7 (S4074 and WF83) and 
field isolates HS25 and HS77, was digested 
with EcoRI, separated on agarose gel and 
blotted. The blot was hybridised with a 
PCR product containing the first half of 
apfA as a probe. In all four strains, only 
one band hybridised with the probe (Fig. 3) 
indicating that only a single copy of apfA is 
present in the A. pleuropneumoniae genome 
of serotypes 1, 3 and 7. This was confirmed 
by homology searches using the complete 
ApfA or the signal peptide sequence of 
ApfA and the unfinished genome sequences 
of A. pleuropneumoniae serotypes 1, 5b and 
7 (available through BLAST).
Cloning and expression of the apfA gene Electron microscopy on A. pleuropneumoniae 
strains S4074, WF83, HS77, HS25 (Table 1A) grown on LB+NAD agar plates yielded 
no fimbriae-like structures protruding from the cell surface. Similar negative results were 
obtained when the production of ApfA in A. pleuropneumoniae strains grown in a diverse 
set of media including CDM was assessed on Western blots with an antiserum raised against 
a short synthetic peptide with the amino acid sequence CSGGQNGVRKMTELR (Fig. 2) 
in ApfA. These data suggest that fimbriae expression is either tightly regulated or that the 
identified operon is not functional.
In order to ensure that the cloned apfA gene can be translated into protein, the gene was 
cloned in frame with a HIS-tag (Fig. 2) in the expression plasmid pQE30, generating pQE-
ApfA. Western blot analysis with an anti-HIS antibody indicated that upon induction with 
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F1 was transferred to A. pleuropneumoniae 
strain S4074. Western blot analysis of whole 
cell lysates with the anti-fimbriae peptide 
serum indicated the synthesis of the 15 kDa 
subunit protein (Fig. 4, lane 8). Electron 
microscopy demonstrated straight fimbriae 
protruding from the bacterial cell surface 
from the recombinant strain carrying the 
fimbrial operon but not from the parent A. 
pleuropneumoniae S4074 (Fig. 5) or from 
A. pleuropneumoniae S4074 (pGZRS19). 
Together, the data indicate that A. 
pleuropneumoniae carries an intact fimbrial 
operon but that under routine laboratory 
growth conditions the promoter activity may 
be insufficient to stimulate the formation of 
intact fimbriae.
IPTG, E. coli M15 (pREP4; pQE-ApfA) produced an additional protein of approximately 15 
kDa (data not shown) which corresponded to the predicted size of the fusion product, ApfA-
HIS. Similarly, the anti-fimbriae peptide serum reacted with the 15 kDa sized protein (Fig. 
4, lanes 1 and 2).
Expression of recombinant fimbriae in A. pleuropneumoniae To investigate the ability 
of the operon placed under an active promoter to encode for the production of fimbrial 
subunits, a PCR product with primers 25 and 26 (Table 2, Fig. 1) containing the entire 
fimbriae operon of A. pleuropneumoniae S4074 but lacking its own promoter sequence was 
cloned in pGZRS19 downstream of the constitutive SD2 promoter. The resulting plasmid 
pGZRS-F1 was transformed to E. coli XL2. Western blot analysis of whole cell lysates of 
XL2 (pGZRS-F1) demonstrated the presence of an approximately 15 kDa protein (Fig. 4, 
lane 5) that was absent from E. coli carrying the empty plasmid pGZRS19 (Fig. 4, lane 4). 
These data indicate that fimbriae subunits were produced.
To investigate the ability of the operon placed under an active promoter to encode for 
the production and assembly of intact fimbriae in A. pleuropneumoniae, plasmid pGZRS-
FIG. 4. Western blot analysis of fimbriae 
subunit ApfA expressed in E. coli and A. 
pleuropneumoniae clones, stained with anti-
fimbriae peptide serum. Lanes 1 and 2: E. coli 
M15 (pREP4; pQE-ApfA) (2 µl and 0.2 µl), lane 
3: E. coli XL2, lane 4: XL2 (pGZRS19), lane 5: 
XL2 (pGZRS-F1), lane 6: A. pleuropneumoniae 
strain S4074, lane 7: S4074 (pGZRS19) and 
lane 8: S4074 (pGZRS-F1). Arrow indicates the 
position of the fimbriae subunit ApfA (± 15 kDa). 
Molecular size markers are indicated on the right 
(in kDa).
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Role fimbriae in adherence The role of type IV fimbriae of A. pleuropneumoniae 
in adherence was tested in an in vitro assay. LEC were cultured and incubated with A. 
pleuropneumoniae reference strain of serotype 1 S4074, S4074 (pGZRS19) and S4074 
(pGZRS-F1). S4074 adhered to 88% of large LEC with 4.29 bacteria per cell and to 33% of 
small LEC with 1.46 bacteria per cell (Table 3). Adherence of S4074 was not significantly 
influenced by the expression of fimbriae on plasmid (pGZRS-F1) (Table 3).
TABLE 3. Adherence of A. pleuropneumoniae strains S4074, S4074 (pGZRS19) and S4074 (pGZRS-
F1) to small and large LEC after 2 h of incubation. The bacterial inoculum varied from 2.8−5.0 × 108 
CFU. Data represent the mean ± standard error of the mean of three-fold experiments.
Large LEC Small LEC
Strain Percentage of cells 
with adherent 
bacteria
Number of 
bacteria per 
cell1
Percentage of cells 
with adherent 
bacteria
Number of 
bacteria per 
cell
S4074 88% ± 9% 4.29 ± 1.31 33% ± 9% 1.46 ± 0.10
S4074 (pGZRS19)  76% ± 18% 6.38 ± 2.59  36% ± 10% 1.55 ± 0.15
S4074 (pGZRS-F1) 99% ± 1% 4.93 ± 2.02 37% ± 5% 1.65 ± 0.17
1Only cells with adherent bacteria are taking into account.
FIG. 5. Electron micrographs of A. pleuropneumoniae reference strain S4074 (A) and S4074 (pGZRS-
F1) (B). Bacteria were stained with methylamine tungstate and examined by electron microscopy as 
described in materials and methods. Bars represent 200 nm.
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DISCUSSION
In the present study we identified and characterised the A. pleuropneumoniae gene cluster 
that facilitates the biogenesis of type IV fimbriae. The cluster consisted of four genes (apfA-
apfD) separated by no or only small intergenic sequences and lacked apparent transcriptional 
terminator sequences. Although the overall organisation of the gene cluster resembled that 
of the related bacterial pathogens H. influenzae, A. actinomycetemcomitans and P. multocida 
(Doughty et al., 2000; Fleischmann et al., 1995; May et al., 2001, unfinished genome of 
A. actinomycetemcomitans available through GenBank), the A. pleuropneumoniae cluster 
has several unique features both with regard to the sequence of the major subunit ApfA, its 
position in the genome, and its expression.
Sequence analysis of the major subunit ApfA indicated that it shared many of the typical 
features of type IV subunits including a short signal peptide followed by a hydrophobic 
domain and at least one pair of cysteines. The signal peptide is twice as long as in other 
subunits (Strom and Lory, 1993) and appears to be typical for Pasteurellaceae. Similarly, 
the predicted loop region between the pair of cysteine residues at the C-terminus, which 
comprises the epithelial cell-binding domain in Pseudomonas aeruginosa (Hahn, 1997), 
contains a motif with the sequence FPA(N/G)F that appears to be conserved among 
Pasteurellaceae. Interestingly, subunits of H. influenzae and A. pleuropneumoniae differ 
only in 2 out of 12 amino acids in this region.
The most striking finding with regard to ApfA however, was the presence of an Ala residue 
at position -1 relative to the ApfA cleavage site. This Ala (-1) was conserved among all 42 
A. pleuropneumoniae isolates that were investigated. The consensus cleavage site of type 
IV fimbriae subunits consists of the the residues Gly (-1), Phe (+1) and Glu (+5) (Strom and 
Lory, 1993). In P. aeruginosa, all but one mutation at residue -1 resulted in lack of processing 
of the major subunit PilA (Strom and Lory, 1991). Partial processing of PilA was observed 
with a mutation to Ala (-1) but this did not result in production of intact pili (Strom and Lory, 
1991). FimT of P. aeruginosa contains a prepilin-like leader sequence and also carries an Ala 
(-1). The fimT gene does not encode a fimbrial subunit but plays a role in fimbrial biogenesis 
(Alm and Mattick, 1996). Other proteins with type IV leader sequences with an Ala (-1) 
include the fimbrial subunit PilE
L
 of Legionella pneumophila that can be assembled in intact 
fimbriae (Stone and Abu Kwaik, 1998) and five archeal proteins with type IV signal peptides 
(Albers and Driessen, 2002). The consequences of the presence of an Ala (-1) in the ApfA 
protein are not clear. In our hands, cloning of the fimbrial cluster onto an expression vector in 
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A. pleuropneumoniae did result in the expression of ApfA and the formation of fimbriae at the 
bacterial cell surface. This indicates that the Ala (-1) does not preclude fimbriae biogenesis. At 
this time we do not know whether the ApfD protein of A. pleuropneumoniae that cleaves the 
ApfA protein has unique characteristics with respect to cleavage activity in comparison with 
other prepilin peptidases or whether ApfA is cleaved at a reduced efficiency. The latter may 
affect the number or quality of the fimbriae. Putative prepilin peptidases of Pasteurellaceae 
appear to lack a cluster of Cys residues in the N-terminal half of the protein. Mutational 
analysis showed that the Cys residues are required for both cleavage and methylation activity 
of PilD (Strom et al., 1993a). However, naturally occuring leader peptidases lacking the Cys 
residues can be fully functional (Hu et al., 1995).
With regard to the position of the fimbrial gene cluster in the genome of A. 
pleuropneumoniae, it was remarkable that the apfA gene was preceded by radA, whereas 
in A. actinomycetemcomitans, P. multocida and H. influenzae the fimbriae subunit gene is 
preceded by ampD (Doughty et al., 2000; Fleischmann et al., 1995; unfinished genome of 
A. actinomycetemcomitans available through GenBank). The frequent clustering of ampD 
with fimbrial operons in other species and the fact that radA in other species is located 
in another section of the genome suggests that rearrangements have taken place in the A. 
pleuropneumoniae genome. Downstream, the fimbriae operon in A. pleuropneumoniae 
was flanked by yacE as was found in A. actinomycetemcomitans, P. multocida, P. 
aeruginosa, Vibrio cholera, Vibrio vulnificus, Aeromonas hydrophila, E. coli and Neisseria 
gonorrhoeae (Fullner and Mekalanos, 1999; May et al., 2001; unfinished genome of A. 
actinomycetemcomitans available through GenBank). In H. influenzae, yacE is located in 
another section of the genome. Overall, the G+C percentage of the A. pleuropneumoniae type 
IV fimbriae genes was 38.44%. This value is slightly lower than the 42−43% G+C content of 
the flanking regions of the operon (including yacE) and of the A. pleuropneumoniae genome 
(Mannheim, 1984) and may indicate an exogenous origin of the fimbriae locus.
Another important conclusion from our work was that the A. pleuropneumoniae fimbriae 
cluster lacks an active promoter at least under the growth conditions employed. This has been 
noticed before (Stevenson et al., 2003; Zhang et al., 2000). Expression of the cluster from 
an expression vector did yield intact fimbriae indicating that the fimbrial genes were intact 
and that the A. pleuropneumoniae strain that was used as a host was capable to assemble 
fimbriae. In other species, type IV fimbriae expression is either constitutive or regulated by 
environmental factors (Winther-Larsen and Koomey, 2002). At this time, the exact conditions 
for fimbriae expression and the regulatory elements involved remain to be defined.
CHAPTER 4
72 73
TYPE IV FIMBRIAE IN A. PLEUROPNEUMONIAE
Expression of fimbriae in A. pleuropneumoniae S4074 (pGZSR-F1) from a constitutive 
promoter did not influence adherence to LEC. The most simple explanation for this is that 
the fimbriae-mediated adherence was masked by activity of other bacterial surface adhesins. 
Alternatively, it is possible that the type IV fimbriae of A. pleuropneumoniae exhibit cell 
type specificity and do not interact with LEC or that they function in other events e.g. 
modulation of the inflammatory response. Furthermore, it can be imagined that adherence 
requires the presence of additional fimbriae-associated proteins. In Neisseria meningitidis 
and N. gonorrhoeae adherence is mediated by PilC present at the tip of the fimbriae (Nassif 
et al., 1994). A homologue of PilC is also found in P. aeruginosa and is required for pilus 
biogenesis (Alm et al., 1996). A PilC homologue was not identified in the fimbriae operon 
of A. pleuropneumoniae. Future studies will be needed to discriminate between these 
possibilities.
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ABSTRACT
We recently demonstrated that the type IV fimbriae operon of Actinobacillus 
pleuropneumoniae is not expressed under routine laboratory conditions due to a lack of 
promoter activity. To study the conditions necessary for fimbriae expression, the fimbriae 
promoter region of A. pleuropneumoniae S4074 was cloned upstream of promoterless 
luciferase genes in the promoter trap vector pTF86. Fimbriae promoter activity depended 
on the bacterial growth phase and was seen only when bacteria were grown in a chemically 
defined medium. Variation in growth temperature and the availability of iron had only minor 
effects on promoter activity, whereas NAD had no effect. Promoter activity was observed 
when primary cultures of lung epithelial cells (LEC) were infected with  bacteria carrying the 
promoter-reporter constructs. In these assays, promoter activity was found only in bacteria 
adhering to LEC (P < 0.05). Non-adherent bacteria in the culture supernatant exhibited 
no luciferase activity. To ascertain that fimbriae are also expressed in vivo, we assessed 
the activity of the fimbriae promoter after endobronchial inoculation of pigs. In pigs, the 
fimbriae promoter activity exhibited a 15-fold higher activity compared to in vitro conditions. 
These data indicate that the type IV fimbriae promoter of A. pleuropneumoniae is subject to 
regulation and is active upon cell contact as well as  in vivo.
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INTRODUCTION
Fimbriae or pili are filamentous polymeric structures that protrude from the cell surface 
(Wu and Fives-Taylor, 2001). Type IV fimbriae form an unique class of multifunctional 
fimbriae defined by shared structural features and a conserved biogenesis pathway. They can 
be involved in natural competence (Kennan et al., 2001; Meier et al., 2002; Wolfgang et al., 
1998), adherence (Hahn, 1997; Nassif et al., 1997; Paranjpye et al., 1998; Stone and Abu 
Kwaik, 1998; Strom and Lory, 1993), protein export (Fullner and Mekalanos, 1999; Hobbs 
and Mattick, 1993; Kennan et al., 2001; Pepe et al., 1996; Rossier and Cianciotto, 2001) 
and twitching motility (Mattick, 2002). Several genes have been identified to be involved in 
fimbriae biogenesis or regulation (Alm and Mattick, 1997). Regulation of type IV fimbriae 
expression differs between species (Strom and Lory, 1993; Winther-Larsen and Koomey, 
2002). The best understood regulatory systems involve transcriptional modulation of the 
fimbriae subunit gene. In Pseudomonas aeruginosa, the PilS/R sensor-response regulator 
pair (Hobbs et al., 1993) and the alternative sigma factor σ54 (Ishimoto and Lory, 1989) are 
essential for pilA transcription. In Neisseria meningitidis, pilE utilises a σ70 promoter (Carrick 
et al., 1997) and expression of pili is down regulated upon cell contact by CrgA (Deghmane 
et al., 2002).
Fimbriae have been found in extremely diverse groups of Gram-negative species (Strom 
and Lory, 1993) and their number is increasing. Recently, the type IV fimbriae operon of 
Actinobacillus pleuropneumoniae serotype 1 was identified (Chapter 4), although expression 
of the fimbriae subunit ApfA was not observed under the various growth conditions 
employed. Expression of the entire operon placed downstream a constitutive promoter 
resulted in the production of ApfA and the formation of intact fimbriae at the surface of A. 
pleuropneumoniae, indicating that the intrinsic apfA promoter is either defective or subject 
to regulation (Chapter 4). 
The aim of this study was to investigate the conditions necessary for activity of the type 
IV fimbriae promoter of A. pleuropneumoniae. Activity of the fimbriae promoter was found 
only in chemically defined medium in bacteria grown to mid- to late-log phase. In addition, 
fimbriae promoter activity was induced in bacteria adhering to lung epithelial cells and to the 
lungs of pigs.
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MATERIALS AND METHODS
Bacterial strains, growth conditions and plasmids A. pleuropneumoniae reference 
strain S4074 (serotype 1), was grown in brain heart infusion (BHI, Gibco BRL, Paisley, 
UK) medium containing 0.008% ß-nicotinamide adenine dinucleotide (NAD, Calbiochem, 
La Jolla, USA) with or without 1.5% Bacto Agar (Becton Dickinson B.V., Alphen a/d 
Rijn, The Netherlands). Escherichia coli strain XL2-blue (Stratagene, La Jolla, California, 
USA) was used for plasmid construction and analysis. When appropriate, ampicillin (Amp) 
was added to the growth medium at a concentration of 100 µg/ml (E. coli) or 5 µg/ml (A. 
pleuropneumoniae). Bacteria were grown at 37°C unless indicated otherwise.
Plasmids pTF86 and pSD2 (Doree and Mulks, 2001) were kindly provided by Dr. 
Martha H. Mulks (Michigan State University, East Lansing, Michigan, USA). pTF86 is a 
promoter-trap vector that contains, in sequence, the T4 terminator, a unique BamHI site and 
a promoterless copy of the V. harveyi luxAB genes in the E. coli-A. pleuropneumoniae shuttle 
vector pGZRS19. pSD2 is based on pTF86 and contains the constitutive promoter SD2. 
pKUN (Konings et al., 1987) was used for cloning.
Preparation of inocula For preparation of inocula, A. pleuropneumoniae strains were 
grown in 5 ml BHI + 0.008% NAD + Amp for 16 h. Bacteria were washed with phosphate 
buffered saline (PBS: 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na
2
HPO
4
, 2.8 mM K
2
HPO
4
, 
pH 7.2) and diluted to approximately 2 × 106 colony forming units (CFU)/ml in PBS. The 
number of CFU before and after inoculation was determined by plating tenfold dilutions in 
threefold on BHI+NAD+Amp agar plates.
PCR reactions PCR was carried out by using the Takara ExTaqTM kit reagents (Takara 
Shuzo Co., Ltd., Otsu, Shiga, Japan) according to the supplied protocol. Each 50 µl PCR 
reaction contained 50 ng of template DNA, 15 pmol of primer, 200 µM of deoxynucleoside 
triphosphate mix, 1× PCR buffer and 1.25 units of enzyme. The amplification cycle used was 
10 min at 94°C, 30 cycles of 15 s at 94°C, 30 s at 60°C, 30 s at 72°C, followed by 7 min at 
72°C. All PCR reactions were performed on a Primus 96 (MWG Biotech AG, Ebersberg, 
Germany).
DNA manipulations Plasmid DNA was isolated by using the Miniprep or Midiprep 
Wizard kit (Promega Corporation, Madison, Wisconsin, USA). DNA ligations were done 
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by using the rapid ligation kit (Roche Diagnostics GmbH, Roche Molecular Biochemicals, 
Mannheim, Germany). Transformation of A. pleuropneumoniae was done as described 
(Chapter 4). Transformation of E. coli XL2 was done according to the instructions supplied 
by the manufacturer.
Cloning A PCR product with primers (5’-CGGGATCCCGAAACGCGTTAGTAAG
CGG-TCG) and (5’-CGGGATCCCGCATATCCGCTGAAGCGGTCGC) containing the 
fimbriae promoter region of A. pleuropneumoniae S4074 was cloned in pKUN with BamHI 
generating pKUN-F. Locations of the primers are 1177-1158 and 791-813 and correspond 
to the nucleotide sequence of the fimbriae operon (GenBank accession number AY235719). 
Underlined nucleotides are not exact matches to the sequence and were altered to add 
restriction enzyme sites. A 320 bp BamHI fragment from pKUN-F was cloned in front of the 
promoterless luxAB genes in pTF86 generating pTF-F (orientation for the fimbriae promoter) 
and pTF-R (orientation for the radA promoter). The orientations of the inserts in pTF-F and 
pTF-R were confirmed by restriction analysis with EcoRI and BglII and sequence analysis.
DNA sequencing and analysis The DNA sequences were determined by Plant Research 
International (Wageningen, The Netherlands) by using the BigDyeTerminator mix (version 
2.0, Applied Biosystems, Forster City, California, USA). Reactions contained 500 ng of 
template plasmid DNA, 4 µl of reaction mix, and 10 pmol of primer in a 10 µl volume. 
Cycle sequencing reactions were performed on a Primus 96 (MWG Biotech). In all cases, 
both strands were sequenced. Sequence analysis was performed using the DNAstar software 
package (DNAstar Inc., Madison, Wisconsin, USA).
Lux analysis Quantitative analysis of Lux expression was performed on a VictorTM 1420 
multilabel counter (Wallac, Turku, Finland). N-decyl aldehyde (Sigma Chemical Co., St. 
Louis, MO, USA) substrate was made by dissolving 20 mg/ml Essentially Fatty Acid Free 
BSA (Sigma) in 1 ml of H
2
O with 1 µl/ml N-decyl aldehyde. This mixture was incubated 
in a glass screw cap test tube for 30 min in a sonicating water bath at room temperature to 
disperse the N-decyl aldehyde into micelles. For Lux analysis, 20 µl of bacterial lysate was 
mixed with 20 µl of substrate in white polysorb luminescence plates (Nunc Gmbh & Co. 
KG, Wiesbaden, Germany). This mixture was then read with normal emission aperture, a 
delay of 5 s, and counting time of 10 s. Luminometer readings (counts per second (CPS)) 
were normalised to the number of bacteria in the sample as determined by plate counts on 
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selective media (µCPS/CFU) or to the OD
600
 for pure cultures of bacteria. An OD
600
 of 1.0 
equals approximately 1 × 109 CFU/ml.
Promoter activity in vitro To investigate promoter activity in vitro, overnight cultures 
of A. pleuropneumoniae strains grown in BHI + 0.008% NAD + Amp were diluted ten times 
in 5 ml BHI + 0.008% NAD + Amp and incubated for 3 h at 37°C without shaking. Bacteria 
were washed once with test medium and resuspended in test medium. Test media included 
BHI + 0.008% NAD, chemically defined medium (CDM, Herriott et al., 1970), CDM + 
20 µM FeSO
4
 and CDM + 0.03% NAD and all media were supplemented with 5 µg/ml 
Amp. Bacteria were incubated in test medium for 2 h at 37°C without shaking. OD
600
 was 
determined and 2.5 ml of culture was centrifuged for 10 min at 5,500 × g at 4°C and pellets 
were resuspended in 40 µl lysis buffer (50 mM KCl, 2.5 mM MgCl
2
, 1.8 µM SDS, 15 mM 
Tris·HCl) and directly used for Lux quantitation.
Promoter activity in the presence of LEC The isolation and culture of porcine lung 
epithelial cells (LEC) were done as described (Boekema et al., 2003). Overnight bacterial 
cultures were centrifuged and the pellets were resuspended in Dulbecco’s modified Eagles 
medium (DMEM, Gibco). Approximately 108 CFU/ml were incubated with cell monolayers 
of LEC in the presence of 5 µg/ml Amp at 37°C in a 5% CO
2
 atmosphere. After 2 hours, 
supernatant medium with non-adherent bacteria was removed and kept at 4°C. LEC were 
washed four times with 3 ml of PBS. Adherent bacteria were released by treating the cell 
monolayers with 1% Triton X-100 in PBS (for 1 min). Controls consisted of bacteria 
incubated with medium alone. For additional controls, bacteria that were incubated with 
medium alone, were centrifuged for 10 min at 5,500 × g at 4°C and were resuspended in 1% 
Triton X-100 in PBS (for 1 min). The numbers of CFU in supernatant medium and medium 
alone, and of Triton X-100 treated bacteria and adherent bacteria were determined by plating 
tenfold dilutions in threefold on BHI+NAD+Amp agar plates. One ml of each suspension 
was centrifuged for 10 min at 5,500 × g at 4°C. The pellets were resuspended in 20 µl lysis 
buffer and directly used for Lux quantitation.
Promoter activity in vivo Animal experiments were performed in three similar, consecutive 
trials in high health pigs free of A. pleuropneumoniae. The pigs were about five weeks of age 
and were housed in sterile stainless steel isolators. For endobronchial infection, pigs were 
anesthetised with a combination of azaperone (Stresnil; Jansen Pharmaceutica B.V., Tilburg, 
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The Netherlands) and ketamine hydrochloride (ketamine; Kombivet B.V., Etten-Leur, The 
Netherlands). Inoculation was performed as previously described (Van Leengoed and Kamp, 
1989). Briefly, a catheter with an outer diameter of 2.2 mm was advanced through the trachea 
deep into the bronchi and 5 ml of bacterial suspension was slowly administered. Three pigs 
per group were inoculated with approximately 107 CFU of A. pleuropneumoniae S4074 
containing plasmids pTF86, pTF-F or pSD2. The average inocolum contained 8.5 106 CFU. 
Two hours post infection, pigs were anesthetised by intravenous injection of pentobarbital 
and exsanguinated. The lungs were excised and three tissue specimens of approximately 1 
cm3 were taken from both distal caudal lung lobes for Lux analysis. Tissues were minced 
with scalpels and 1.5 ml of PBS was added. Tissue suspensions were transferred to 5 ml 
tubes, mixed for 5 s and centrifuged for 5 min at 200 × g to remove large clumps of tissue. 
Bacterial concentrations of the supernatant were determined by plating tenfold dilutions on 
BHI+NAD+Amp agar plates. One ml of supernatant was centrifuged for 5 min at 10,000 × 
g. The pellets were resuspended in 100 µl lysis buffer and directly used for Lux quantitation. 
For Lux analysis, the bacterial lysate was mixed with 100 µl of N-decyl aldehyde.
All animal experiments were approved by the ethical committee of ID-Lelystad.
RESULTS
Cloning of the fimbriae promoter In order to find the molecular basis for the absence 
of type IV fimbriae in A. pleuropneumoniae under routine growth conditions (Chapter 4), 
we focussed on the promoter region of the fimbriae operon. The putative promoter region is 
likely located between the apfA gene and the radA gene that is located more upstream and 
directed in the opposite orientation as the fimbriae operon genes (Chapter 4). To determine 
possible promoter activity in this region, a PCR fragment containing this entire region of 
A. pleuropneumoniae S4074 was cloned with opposite orientations into the reporter vector 
pTF86 in front of the promoterless luxAB genes, generating pTF-F (orientation for the 
fimbriae promoter) and pTF-R (orientation for the radA promoter), respectively. As a control, 
we used plasmid pSD2 containing the constitutive A. pleuropneumoniae promoter SD2 in 
front of the lux genes (Doree and Mulks, 2001). All plasmids (pTF86, pSD2, pTF-F and pTF-
R) were transformed to A. pleuropneumoniae S4074 and the level of expression of the luxAB 
genes was determined by measurement of Lux activity.
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Functionality of the fimbriae promoter The in vitro activity of the fimbriae promoter 
was initially assessed of bacteria carrying the various plasmids grown for 16 h in 
BHI+NAD+Amp or in CDM+Amp and of ten-fold dilutions of these cultures in both media 
grown for 1-4 h. Under these conditions no reproducible Lux activity was measured for 
strain S4074 carrying the pTF-F plasmid, while S4074 carrying pSD2 (positive control) and 
S4074 carrying pTF-R showed strong activity (data not shown). However, when bacteria at 
3 h of exponential growth in BHI were collected by centrifugation, washed, and grown in 
CDM+Amp for an additional 2 h, S4074 carrying pTF-F did exhibit a luciferase activity of 
4,678 µCPS/CFU. This was 26 times higher than the luciferase activity of S4074 (pTF86) 
that carried the promoterless lux genes (P < 0.05, Table 1) but lower than the activities of 
bacteria carrying plasmids pSD2 and pTF-R (Table 1). Similar experiments with bacteria 
grown in the final 2 h of incubation in BHI+NAD+Amp instead of in CDM indicated 
virtually no activity of the putative fimbriae promoter, although good activity was observed 
for the controls pSD2 and pTF-R (Table 1). Together, these data strongly suggest that the 
fimbriae promoter is intact and that its activity (in contrast to that of the radA promoter) 
requires distinct environmental conditions.
Environmental regulation of the fimbriae promoter The discovery of an intact and 
apparently regulated fimbriae promoter led us to assess several possible environmental 
conditions that may regulate the promoter activity. During our experiments, we noticed that 
when overnight cultures were diluted more than ten times in BHI prior to incubation in CDM, 
S4074 (pTF-F) expressed low or no Lux activity in CDM (data not shown) in contrast to the 
TABLE 1 In vitro promoter activity in A. pleuropneumoniae S4074 in BHI+NAD+ Amp 
and in CDM+Amp. The mean results of three experiments in threefold are shown.
BHI+NAD+Amp CDM+Amp
Plasmid Lux activity
(µCPS/CFU)a
Relative 
activityb
Lux activity
(µCPS/CFU)
Relative 
activity
pTF86 90 1 178 1
pSD2 7,307c 81.12 16,691c 93.41
pTF-R 5,426c 60.24 11,588c 64.85
pTF-F 77 0.85 4,678c 26.18
aLux activity is expressed as CPS (counts per second) per OD
600
. An OD
600
 of 1.0 
equals approximately 1 × 109 CFU/ml.
bRelative Lux activity compared to pTF86.
cSignificantly different from pTF86 in the same medium (P < 0.05).
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hypothesis was further tested by measurement of Lux activity after dilution (1:1) of cultures 
of S4074 (pTF86) and S4074 (pTF-F) grown in BHI with sterile culture supernatant of S4074 
(pTF-F) grown in CDM. This procedure did not enhance Lux activity (data not shown), 
suggesting that the assumed factors (if present) were not sufficient to stimulate the fimbriae 
promoter.
For A. pleuropneumoniae serotypes 5a, 9 and 10, fimbriae expression has been reported 
to be related with a low NAD (0.001%) concentration in the medium (Van Overbeke et al., 
2002). In our hands, growth in CDM containing NAD concentrations between 0.0004% and 
0.03% NAD did not result in alteration of Lux activities for strains S4074 (pTF86), S4074 
(pSD2), S4074 (pTF-R) or S4074 (pTF-F) (P > 0.05, 1 experiment in threefold, Table 2) 
indicating that NAD is not a critical determinant of fimbriae promoter activity.
Many bacterial pathogens respond to the low iron concentration encountered in vivo by 
expressing of a wide variety of virulence determinants. Therefore, the possible role of Fe2+ on 
fimbriae promoter activity in CDM was investigated. When iron limitation is involved in the 
regulation of fimbriae expression, fimbriae promoter activity should be abolished or greatly 
reduced in the presence of an excess of iron. Growth of the strains carrying the various 
plasmids in CDM in the presence of 20 µM FeSO
4 
yielded unaltered Lux activities for strains 
S4074 (pTF86), S4074 (pSD2) and S4074 (pTF-R), while the relative Lux activity of S4074 
(pTF-F) was only slightly decreased (by a factor 1.82) (P < 0.05, 3 experiments in threefold, 
Table 2). This suggests that iron availability may play a (minor) role in fimbriae expression.
To get further insight into the exact requirements for fimbriae expression, the effect of 
temperature on fimbriae promoter activity was tested. The Lux activity of S4074 (pTF86), 
S4074 (pSD2) and S4074 (pTF-R) was not affected by an incubation temperature of 33°C 
controls S4074 (pSD2) and S4074 (pTF-R) 
(data not shown). This observation could 
indicate that the growth phase or a particular 
density of the bacteria was important for 
the induction of fimbriae promoter activity. 
One mechanism by which bacterial density 
may influence gene transcription is via the 
secretion of factors that influence gene 
transcription (quorum factors). The latter 
TABLE 2 Influence of culture conditions on in 
vitro promoter activity in A. pleuropneumoniae 
S4074 in CDM. 
Plasmid 0.03% NAD 20 µM FeSO
4
33°C
pSD2 1.21a 0.99 0.89
pTF-R 1.01 0.99 0.85
pTF-F 1.24 0.55b 1.60b
aRelative Lux activity compared to relative Lux 
activity in CDM.
bSignificantly different from CDM (P < 0.05).
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compared to 37°C (Table 2). The relative Lux activity of S4074 (pTF-F) at 33°C was slightly 
increased by a factor 1.60 compared to Lux activity at 37°C (P < 0.05, 2 experiments in 
threefold, Table 2), suggesting that also temperature may have a (minor) effect on fimbriae 
expression. The relative Lux acitivities of S4074 (pTF86), S4074 (pSD2), S4074 (pTF-R) 
were unaltered in the conditions tested (Table 2).
In vitro activity of the fimbriae promoter in the presence of LEC The apparent strict 
growth conditions required for fimbriae promoter activity led us to test the activity of the 
promoter under more native conditions in the presence of lung epithelial cells (LEC). A. 
pleuropneumoniae S4074 containing plasmids pTF86, pSD2, pTF-R or pTF-F were incubated 
in the presence of LEC for 2 h and then Lux activities of the bacteria in the supernatant as 
well as of the adherent bacteria were determined (Table 3). As controls, Lux activities of 
bacteria in medium (without LEC) and of bacteria treated with Triton X-100 were determined. 
Lux activity of the negative control strain S4074 (pTF86) was low under all conditions and 
ranged from 93 to 318 µCPS/CFU (Table 3). Lux activities of the controls S4074 (pSD2) and 
S4074 (pTF-R) were high under all conditions and ranged from 3,231 to 17,432 µCPS/CFU. 
These activities were 16 to 188 times higher than luciferase activities of S4074 (pTF86) 
(Table 3). Lux activity of S4074 (pTF-F) was observed only in bacteria adhering to LEC (P < 
0.05) and was 1,523 µCPS/CFU. This activity was substantially higher than that of the non-
adherent bacteria in the supernatant and of the negative control strain S4074 (pTF86) (Table 
3) irrespective of the presence of Triton X-100. Together, these data clearly indicate that the 
fimbriae promoter becomes active when bacteria adhere to the cell surface.
TABLE 3 Influence of LEC on in vitro promoter activity in A. pleuropneumoniae S4074. The mean 
results of six experiments are shown.
Bacteria treated 
with medium alone
Bacteria in 
supernatant of LEC
Bacteria binding 
to LEC
Bacteria treated 
with Triton
Plasmid Lux 
activitya
Relative 
activityb
Lux 
activity
Relative 
activity
Lux 
activity
Relative 
activity
Lux 
activity
Relative 
activity
pTF86 318 1 295 1 93 1 139 1
pSD2 15,893c 50.06 15,936c 53.95 17,432c 188.33 5,646c 40.52
pTF-R 9,229c 29.07 4,851c 16.42 5,970c 64.49 3,231c 23.19
pTF-F 214 0.67 221 0.75 1,523c 16.45 117 0.84
aLux activity is expressed as µCPS/CFU.
bRelative Lux activity compared to pTF86.
cSignificantly different from pTF86 in the same suspension (P < 0.05).
CHAPTER 5
86 87
FIMBRIAE PROMOTER ACTIVITY
was low (326 µCPS/CFU, Table 4) and the in vivo Lux activity of the strain with the 
consitutive expressed lux genes in S4074 (pSD2) was very high (22,601 µCPS/CFU, Table 
4). The in vivo Lux activity of S4074 (pTF-F), carrying the fimbriae promoter in the correct 
orientation was 1,176 µCPS/CFU (Table 4) and was substantially higher than the negative 
control (P < 0.05) (Table 4). The ratio of in vivo Lux activity to in vitro Lux activity in BHI 
was 15 for the fimbriae promoter (Table 4). The in vivo Lux activity of S4074 (pTF-F) was 
comparable to the Lux activity of S4074 (pTF-F) binding to LEC (Table 3). These results 
strongly suggest that the fimbriae promoter is active in vivo during infection of lung tissue. 
DISCUSSION
In the present work, we discovered that the promoter activity driving the production of 
type IV fimbriae of A. pleuropneumoniae is subject to environmental regulation. Fimbriae 
production is induced by contact with epithelial cells in vitro and during experimental 
infection of the lungs of pigs.
The strategy that was used to investigate whether the fimbriae promoter was intact and 
subject to regulation, involved the construction of a transcriptional fusion with cloning of 
the type IV fimbriae promoter region of A. pleuropneumoniae S4074 into a promoter trap 
vector carrying the luxAB reporter genes. This approach demonstrated that the DNA region 
preceding the fimbriae operon carried two promoters: the fimbriae promoter with variable 
activity dependent on the environmental conditions and, on the opposite strand, the radA 
promoter that appeared to be constitutively active and thus served as a control. The variable 
fimbriae promoter activity clearly showed that the fimbriae promoter was intact and that 
TABLE 4 In vivo promoter activity in A. 
pleuropneumoniae S4074. The mean results of 
three tissue specimens of three pigs are shown.
Plasmid Lux 
activitya
Relative 
activityb
Ratio in vivo 
to in vitro 
(BHI)
pTF86 326 1 3.62
pTF-F 1,176c 3.61 15.27
pSD2 22,601c 69.29 3.09
aLux activity is expressed as µCPS/CFU.
bRelative Lux activity compared to pTF86.
cSignificantly different from pTF86 (P < 0.05).
In vivo activity of the fimbriae promoter 
To test the activity of the fimbriae promoter 
in vivo, A. pleuropneumoniae S4074 
containing plasmids pTF86, pSD2 or pTF-F 
were used for endobronchial inoculation of 
pigs. Two hours after inoculation, pigs were 
sacrificed and the Lux activity of minced 
lung tissue was determined and related to 
the number of CFU (Table 4). As expected, 
the in vivo Lux activity of the strain with the 
promoterless luxAB genes, S4074 (pTF86), 
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the lack of type IV fimbriae observed after growth in routine growth media was caused by 
regulation of promoter activity rather than by an intrinsic defect in the promoter region. 
The first evidence that the fimbriae promoter was subject to regulation was that the 
luciferase activity varied with the bacterial growth phase and the growth medium. Fimbriae 
promoter activity was found in cultures grown to mid- to late-log phase in chemically 
defined media but not when grown in BHI. These data may provide the genetic basis for 
the observations made by Zhang et al. (2000) who was only able to detect fimbriae when 
A. pleuropneumoniae were grown in CDM under microaerophilic conditions. It has been 
reported that in certain A. pleuropneumoniae serotypes (5a, 9 and 10) but not in others 
(serotype 2) NAD restriction is a critical factor for fimbriae production (Van Overbeke et al., 
2002). In our hands, variation in the concentration of NAD did not influence the activity of 
the fimbriae promoter which was derived from a serotype 1 strain. Together, the data suggest 
the existence of serotype specific differences in the regulation of fimbriae promoter activity.
The exact signals that drive fimbriae promoter activity in serotype 1 are unknown. We 
noticed that changes in temperature, which influence fimbriae expression in Legionella 
pneumophila (Liles et al., 1998) and Porphyromonas gingivalis (Xie and Lamont, 1999), 
or the availability of iron had minor effects. These effects are probably not very specific 
and may well be related to concomitant changes in growth phase that appear to influence 
fimbriae promoter activity. We cannot conclude whether apfA induction was directly growth 
phase dependent or whether it was due to deprivation of a specific essential nutrient. A 
strong induction of fimbriae promoter activity was observed for A. pleuropneumoniae that 
were adherent to primary cultures of lung epithelial cells. This interesting finding indicates 
that contact with epithelial cells is a trigger for fimbriae production. The importance of a 
more natural setting for the induction of fimbriae promoter activity was further underlined 
by our finding that the fimbriae promoter was active in vivo after endobronchial inoculation 
of pigs. The in vivo Lux activity appeared less than that observed for the bacteria adherent 
to the cultured lung cells but this may be explained by the fact that we measured the 
total Lux activity in all bacteria (both adherent and non-adherent) present in the tissue 
samples. The 15-fold induction of fimbriae promoter activity in vivo compared to BHI in 
A. pleuropneumoniae is similar to inductions found in a recent study of in vivo induced 
promoters in A. pleuropneumoniae which were identified with an IVET system (Fuller et al., 
1999).
The fimbriae promoter activity in vivo suggests that fimbriae play a role in the pathogenesis. 
On the basis of the functions of type IV fimbriae in other bacterial pathogens, it is tempting to 
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speculate that the fimbriae of A. pleuropneumoniae play a role in the adherence and, possibly, 
at other stages of the infection e.g. in the regulation of the inflammatory response, and that 
these roles may require transient expression.
ACKNOWLEDGEMENTS
We thank Martha Mulks (Michigan State University, East Lansing, Michigan, USA) for 
providing plasmids pTF86 and pSD2.
REFERENCES
Alm, R.A., and Mattick, J.S. (1997) Genes involved in the biogenesis and function of type-4 fimbriae 
in Pseudomonas aeruginosa. Gene 192: 89-98.
Boekema, B.K.H.L., Stockhofe-Zurwieden, N., Smith, H.E., Kamp, E.M., van Putten, J.P., and 
Verheijden, J.H. (2003) Adherence of Actinobacillus pleuropneumoniae to primary cultures 
of porcine lung epithelial cells. Vet Microbiol 93: 133-144.
Carrick, C.S., Fyfe, J.A., and Davies, J.K. (1997) The normally silent σ54 promoters upstream of the 
pilE genes of both Neisseria gonorrhoeae and Neisseria meningitidis are functional when 
transferred to Pseudomonas aeruginosa. Gene 198: 89-97.
Deghmane, A.E., Giorgini, D., Larribe, M., Alonso, J.M., and Taha, M.K. (2002) Down-regulation of 
pili and capsule of Neisseria meningitidis upon contact with epithelial cells is mediated by 
CrgA regulatory protein. Mol Microbiol 43: 1555-1564.
Doree, S.M., and Mulks, M.H. (2001) Identification of an Actinobacillus pleuropneumoniae consensus 
promoter structure. J Bacteriol 183: 1983-1989.
Fuller, T.E., Shea, R.J., Thacker, B.J., and Mulks, M.H. (1999) Identification of in vivo induced genes 
in Actinobacillus pleuropneumoniae. Microb Pathog 27: 311-327.
Fullner, K.J., and Mekalanos, J.J. (1999) Genetic characterization of a new type IV-A pilus gene cluster 
found in both classical and El Tor biotypes of Vibrio cholerae. Infect Immun 67: 1393-1404.
Hahn, H.P. (1997) The type-4 pilus is the major virulence-associated adhesin of Pseudomonas 
aeruginosa--a review. Gene 192: 99-108.
Herriott, R.M., Meyer, E.Y., Vogt, M., and Modan, M. (1970) Defined medium for growth of 
Haemophilus influenzae. J Bacteriol 101: 513-516.
Hobbs, M., Collie, E.S., Free, P.D., Livingston, S.P., and Mattick, J.S. (1993) PilS and PilR, a two-
component transcriptional regulatory system controlling expression of type 4 fimbriae in 
CHAPTER 5
90 91
FIMBRIAE PROMOTER ACTIVITY
Pseudomonas aeruginosa. Mol Microbiol 7: 669-682.
Hobbs, M., and Mattick, J.S. (1993) Common components in the assembly of type 4 fimbriae, DNA 
transfer systems, filamentous phage and protein-secretion apparatus: a general system for the 
formation of surface-associated protein complexes. Mol Microbiol 10: 233-243.
Ishimoto, K.S., and Lory, S. (1989) Formation of pilin in Pseudomonas aeruginosa requires the 
alternative sigma factor (RpoN) of RNA polymerase. Proc Natl Acad Sci U S A 86: 1954-
1957.
Kennan, R.M., Dhungyel, O.P., Whittington, R.J., Egerton, J.R., and Rood, J.I. (2001) The type IV 
fimbrial subunit gene (fimA) of Dichelobacter nodosus is essential for virulence, protease 
secretion, and natural competence. J Bacteriol 183: 4451-4458.
Konings, R.N., Verhoeven, E.J., and Peeters, B.P. (1987) pKUN, vectors for the separate production of 
both DNA strands of recombinant plasmids. Methods Enzymol 153: 12-34.
Liles, M.R., Viswanathan, V.K., and Cianciotto, N.P. (1998) Identification and temperature regulation 
of Legionella pneumophila genes involved in type IV pilus biogenesis and type II protein 
secretion. Infect Immun 66: 1776-1782.
Mattick, J.S. (2002) Type iv pili and twitching motility. Annu Rev Microbiol 56: 289-314.
Meier, P., Berndt, C., Weger, N., and Wackernagel, W. (2002) Natural transformation of Pseudomonas 
stutzeri by single-stranded DNA requires type IV pili, competence state and comA. FEMS 
Microbiol Lett 207: 75-80.
Nassif, X., Marceau, M., Pujol, C., Pron, B., Beretti, J.L., and Taha, M.K. (1997) Type-4 pili and 
meningococcal adhesiveness. Gene 192: 149-153.
Paranjpye, R.N., Lara, J.C., Pepe, J.C., Pepe, C.M., and Strom, M.S. (1998) The type IV leader 
peptidase/N-methyltransferase of Vibrio vulnificus controls factors required for adherence to 
HEp-2 cells and virulence in iron-overloaded mice. Infect Immun 66: 5659-5668.
Pepe, C.M., Eklund, M.W., and Strom, M.S. (1996) Cloning of an Aeromonas hydrophila type IV pilus 
biogenesis gene cluster: complementation of pilus assembly functions and characterization of 
a type IV leader peptidase/N-methyltransferase required for extracellular protein secretion. 
Mol Microbiol 19: 857-869.
Rossier, O., and Cianciotto, N.P. (2001) Type II protein secretion is a subset of the PilD-dependent 
processes that facilitate intracellular infection by Legionella pneumophila. Infect Immun 69: 
2092-2098.
Stone, B.J., and Abu Kwaik, Y. (1998) Expression of multiple pili by Legionella pneumophila: 
identification and characterization of a type IV pilin gene and its role in adherence to 
mammalian and protozoan cells. Infect Immun 66: 1768-1775.
CHAPTER 5
90 91
FIMBRIAE PROMOTER ACTIVITY
Strom, M.S., and Lory, S. (1993) Structure-function and biogenesis of the type IV pili. Annu Rev 
Microbiol 47: 565-596.
Van Leengoed, L.A., and Kamp, E.M. (1989) Endobronchial inoculation of various doses of 
Haemophilus (Actinobacillus) pleuropneumoniae in pigs. Am J Vet Res 50: 2054-2059.
Van Overbeke, I., Chiers, K., Charlier, G., Vandenberghe, I., Van Beeumen, J., Ducatelle, R., 
and Haesebrouck, F. (2002) Characterization of the in vitro adhesion of Actinobacillus 
pleuropneumoniae to swine alveolar epithelial cells. Vet Microbiol 88: 59-74.
Winther-Larsen, H.C., and Koomey, M. (2002) Transcriptional, chemosensory and cell-contact-
dependent regulation of type IV pilus expression. Curr Opin Microbiol 5: 173-178.
Wolfgang, M., Lauer, P., Park, H.S., Brossay, L., Hebert, J., and Koomey, M. (1998) PilT mutations 
lead to simultaneous defects in competence for natural transformation and twitching motility 
in piliated Neisseria gonorrhoeae. Mol Microbiol 29: 321-330.
Wu, H., and Fives-Taylor, P.M. (2001) Molecular strategies for fimbrial expression and assembly. Crit 
Rev Oral Biol Med 12: 101-115.
Xie, H., and Lamont, R.J. (1999) Promotor architecture of the Porphyromonas gingivalis fimbrillin 
gene. Infect Immun 67: 3227-3235.
Zhang, Y., Tennent, J.M., Ingham, A., Beddome, G., Prideaux, C., and Michalski, W.P. (2000) 
Identification of type 4 fimbriae in Actinobacillus pleuropneumoniae. FEMS Microbiol Lett 
189: 15-18.

Chapter 6
General Discussion
95
GENERAL DISCUSSION
95
GENERAL DISCUSSION
Actinobacillus pleuropneumoniae causes pleuropneumonia, a disease that has severe 
impact in the pig rearing industry world-wide. Although progress has been made in controlling 
the disease, current available whole cell or subunit vaccines do not provide full protection. 
These vaccines protect against clinical symptoms but they do not prevent colonisation and 
subsequent spread of the disease. Development of new, efficient tools for successful control 
and prevention requires better understanding of the pathogenesis. In the present work, we 
addressed this topic by studying the interaction of A. pleuropneumoniae with host cells in a 
novel sophisticated infection model of primary cultures of porcine lung epithelial cells and 
investigated the possible role of three potential virulence factors in the infection: fimbriae, 
lipopolysaccharide (LPS) and the RTX toxins. Fimbriae mediate adherence in a number of 
species and have been isolated recently from A. pleuropneumoniae. Bacterial adherence is 
believed to be essential for bacterial colonisation. LPS was investigated because of reports 
about its involvement in adherence of A. pleuropneumoniae to epithelial cells. The RTX 
toxins ApxI, ApxII and ApxIII are essential in the development of clinical symptoms and 
lesions typical for A. pleuropneumoniae infections. To assess the surplus value of the 
production of more than one toxin and the relative contribution of ApxI and ApxII to the 
infection, the ability of different Apx mutants of A. pleuropneumoniae to induce lesions was 
investigated.
Interaction of A. pleuropneumoniae with epithelial cells
To study the interaction of A. pleuropneumoniae with host cells in more detail, an in 
vitro model was developed using primary cultures of porcine lung epithelial cells (LEC) 
(Chapter 3). Primary cultures of LEC were used because shortly after intranasal infection, A. 
pleuropneumoniae was found to be predominantly associated with the alveolar epithelium 
and with cilia of the terminal bronchioli (Dom et al., 1994), suggesting that cells of the 
lower respiratory tract may be an important infection target. Aerosol particles produced 
by sneezing or artificially are small enough to penetrate into the lower respiratory tract, 
bypassing the need for colonisation of the upper respiratory tract (Hensel et al., 1995; 
Kaltrieder, 1976). In the LEC model, A. pleuropneumoniae did adhere to LEC indicating 
that adherence to epithelial cells in the lower respiratory tract may constitute an important 
step in the pathogenesis. Adherence results with LEC were compared with data obtained 
with cells of the swine kidney cell line (SK6). A. pleuropneumoniae demonstrated higher 
binding efficiencies to LEC than to SK6 stressing the importance of using organ specific 
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cells. Whether adherence of A. pleuropneumoniae to lower respiratory tract epithelium is 
also host-specific is unknown. Cell lines are commonly used to study adherence in vitro and 
represent a variety of hosts and tissues. They are easily cultured and highly homogenous. 
Only recently a cell line representing the porcine lower respiratory tract epithelium has 
become available but its use in adherence studies has to be determined yet (Seo et al., 
2001). Frozen or paraffin embedded tissue sections have been used to study adherence of A. 
pleuropneumoniae (Jacques et al., 1991; Paradis et al., 1994; Paradis et al., 1999) but results 
with these models must be viewed critically because normally non-exposed domains present 
in these sections may distort results.
Isolated alveolar epithelial cells (AEC) used in adherence studies were characterised by 
the presence of lamellar bodies (Van Overbeke et al., 2002). They represent differentiated 
alveolar type II (ATII) cells which are involved in surfactant production in vivo (Gil and 
Reiss, 1973; Goerke, 1974; Kikkawa et al., 1975). Epithelial cells used for this thesis were 
isolated with a similar procedure as used to isolate AEC but were cultured until confluence 
was reached (Chapter 3). These cultured cells did not contain lamellar bodies but reacted 
with an epithelial cell marker and hence were termed lung epithelial cells (LEC). Incubations 
of viable LEC with A. pleuropneumoniae did not result in lysis of cells. Primary AEC had 
to be methanol-fixed for adherence studies to circumvent the lysis of cells observed after 
incubation of viable AEC with A. pleuropneumoniae or Apx toxins (Van de Kerkhof et al., 
1996; Van Overbeke et al., 2002). Possibly, a difference in toxin susceptibility may be related 
to differences in cell culture conditions, cell differentiation state or exposed cell surfaces. 
Host cell-surface proteins have been demonstrated to participate in toxin activity of Lkt of 
Mannheimia haemolytica and Ltx of Actinobacillus actinomycetemcomitans (Deshpande et 
al., 2002; Lally et al., 1997; Narayanan et al., 2002; Wang et al., 1998). Similar proteins have 
not been described for Apx toxin activities but it can be speculated that these are lost upon 
culture of LEC making them more resistant to Apx toxins compared to AEC. Alternatively, 
bacterial culture conditions may influence toxin production. The resistance of viable LEC to 
Apx toxins makes the LEC culture system an attractive model to study the interaction of A. 
pleuropneumoniae with epithelial cells.
Role of LPS in A. pleuropneumoniae adherence
The role of LPS in adherence of A. pleuropneumoniae to LEC was assessed (Chapter 3). 
LPS and particularly the core region of LPS have been shown to be involved in adherence 
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to tracheal epithelial cells (Belanger et al., 1990; Paradis et al., 1994; Paradis et al., 1999; 
Rioux et al., 1999). In contrast, adherence of A. pleuropneumoniae to LEC was not affected 
by changes in the core region of LPS or by addition of purified LPS (Chapter 3) suggesting 
that different adhesins are involved in adherence to LEC and tracheal cells. Complementation 
of the mutant with an altered core region with the wild type sequence of the affected gene, 
galU, did restore adherence to tracheal epithelium (Rioux et al., 1999). Interestingly, 
this complementation did not restore the core region of LPS leaving the role of LPS in 
adherence to tracheal epithelium unclear (Bosse et al., 2002). Although galU mutants of 
A. pleuropneumoniae, Haemophilus influenzae and Klebsiella pneumoniae exhibit reduced 
virulence, this may be related to an increased sensitivity to non-immune serum (Chang et al., 
1996; Hood et al., 1996; Rioux et al., 1999).
Information on the role of LPS in adherence of other bacterial species is limited and 
knowledge about the adherence conferring moieties is rudimentary. LPS plays a role in 
adherence of Pasteurella multocida, Haemophilus ducreyi and Pseudomonas aeruginosa but 
not in adherence of A. actinomycetemcomitans or H. influenzae type b (Alfa and DeGagne, 
1997; Gupta et al., 1994; Jackson et al., 1996; Jacques et al., 1993; Mintz and Fives-Taylor, 
1994). LPS of non-typeable H. influenzae and of commensal Neisseria spp. contains a 
phosphorylcholine (ChoP) moiety which mediates adherence and invasion (Serino and 
Virji, 2002; Swords et al., 2000). ChoP binds the platelet activating factor receptor present 
on epithelial and endothelial cells. ChoP present on other structures than LPS also mediates 
adherence of Streptococcus pneumoniae and pathogenic Neisseria spp. and invasion of 
endothelial cells by A. actinomycetemcomitans (Berube et al., 1999; Schenkein et al., 2000; 
Serino and Virji, 2000; Sundberg-Kövamees et al., 1996; Weiser et al., 1998). Whether 
A. pleuropneumoniae adhesins contain ChoP is unknown. The major role of LPS in the 
pathogenesis of A. pleuropneumoniae most probably lies in blocking complement mediated 
killing, in scavenging free radicals and in the induction of inflammatory events (Bilinski, 
1991; Lin et al., 1994; Ulich et al., 1991; Ward and Inzana, 1994). This is supported by 
reports on various pathogens where mutations in LPS biosynthesis genes resulted in increased 
serum-sensitivity and reduced survival in vivo (Chang et al., 1996; Hood et al., 1996; Rioux 
et al., 1999; Spears et al., 2000; West et al., 2000).
As discussed, primary cultures of LEC are excellent infection models to study the 
interactions of A. pleuropneumoniae with host cells. For example the role of LPS in 
adherence to LEC was assessed in vitro by using purified LPS and LPS transposon mutants 
(Chapter 3). Advantages of the in vitro LEC culture system include ease and simplicity of 
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experimentation and the use of viable and host-specific cells. Disadvantages of the LEC 
culture system include a probable different profile of surface proteins compared to the in vivo 
situation and the laborious nature of microscopic counting of adherent bacteria. Microscopic 
counting, and not for example plating of adherent bacteria, was chosen because it yields data 
of specific (cell-associated) binding. While cell-contact-dependent regulation of bacterial 
genes and the role of individual adhesins can easily be tested in the LEC assay (Chapters 3 
and 5), screening strategies for identifying putative adhesins require more elaborate methods. 
Cell cultures can be used to screen for factors contributing to adherence by applying a 
signature tagged mutagenesis system for in vitro screening (Badger et al., 2000; Fuller et al., 
2000). Additionally, differential gene expression of pathogen and host can be investigated 
by using microarray analyses of whole bacterial or host genomes (Dietrich et al., 2003; 
Grifantini et al., 2002; Ichikawa et al., 2000).
Role of fimbriae in A. pleuropneumoniae infection
An important conclusion from this thesis is that the A. pleuropneumoniae genome 
harbours a functional type IV fimbrial operon that is expressed in vivo (Chapters 4 and 5). The 
in vivo induced activity of the fimbriae promoter shortly after infection suggests that fimbriae 
play a role in the colonisation and the pathogenesis. This opens opportunities for testing the 
protective efficacy of purified fimbriae. Infection experiments with deletion mutants in pigs 
and challenge experiments with fimbriae immunised animals may provide insight into the 
vaccine potential of A. pleuropneumoniae fimbriae. The apparent tight regulation of fimbriae 
expression in A. pleuropneumoniae, led us to investigate the requirements for fimbriae (apf) 
promoter activity. The promoter trap vector that was used to investigate apf promoter activity 
has been proven to be a valuable tool in identifying putative virulence determinants (Chapter 
5; Fuller et al., 1999). It allows quantification of reporter protein expression and therefore 
the relative strength of the promoter driving the expression both in vitro and in vivo in A. 
pleuropneumoniae. To investigate the in vivo expression of fimbriae in A. pleuropneumoniae, 
pigs were endobronchially inoculated with A. pleuropneumoniae carrying promoter-reporter 
gene fusion constructs. We measured luciferase activity of the reporter protein of all bacteria 
present in homogenised tissue samples, including bacteria adhering to lower respiratory 
epithelium. These adhering bacteria may be especially important since contact to epithelial 
cells in vitro appears to be a trigger for fimbriae expression in A. pleuropneumoniae. Infection 
experiments of LEC with A. pleuropneumoniae carrying reporter constructs showed that the 
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apf promoter was active only in bacteria adhering to epithelial cells and not in bacteria in 
the culture supernatant. Whether the induced fimbriae expression is transient and/or requires 
viable cells remains to be elucidated.
Bacterial contact to eukaryotic cells can be a regulation signal for several virulence 
factors (Deghmane et al., 2002; Dietrich et al., 2003; Taha et al., 1998; Tobe and Sasakawa, 
2001). In for example Neisseria meningitidis, bacterial cell contact induces expression of the 
pilustip-located adhesin PilC1 and of the transcriptional regulator gene crgA, followed by 
down-regulation of fimbriae and capsule expression (Deghmane et al., 2000; Deghmane et 
al., 2002; Grifantini et al., 2002; Taha et al., 1998). Downregulation of fimbriae and capsule 
following cell contact enables the pathogen to switch from initial to intimate adherence. 
It can be speculated that fimbriae expression of A. pleuropneumoniae upon cell contact is 
transient and that A. pleuropneumoniae has a similar ability to switch from initial to intimate 
adherence. In A. pleuropneumoniae, expression of fimbriae is tightly regulated and is induced 
upon cell contact. Adherence to tracheal sections of non-encapsulated transposon mutants of 
A. pleuropneumoniae was increased compared to their parent strains (Rioux et al., 2000), 
suggesting that capsule masks adhesins. In addition, homology searches using the unfinished 
genome of A. pleuropneumoniae (available through BLAST) revealed the presence of 13 
genes in identical order and highly homologous to genes in the tad-cluster which are involved 
in tight adherence of A. actinomycetemcomitans and H. ducreyi (Kachlany et al., 2000; 
Kachlany et al., 2001; Nika et al., 2002). Their putative function in A. pleuropneumoniae 
awaits further investigation.
While little is known about in vivo expression, the in vitro regulation of fimbriae 
expression has been studied in detail in several species (Larribe et al., 1997; Winther-Larsen 
and Koomey, 2002; Wu and Kaiser, 1997). Many bacterial pathogens sense important 
environmental cues and respond by regulating the expression of various genes at the 
transcriptional level, enabling the bacterium to flexibly adapt to the different conditions in the 
host. Examples of signals regulating expression of virulence factors in several Gram-negative 
bacteria are temperature, pH, oxidative stress, host-specific inducers, nutrient deprivation or 
transition into the stationary growth phase (Fullner and Mekalanos, 1999; Iriarte et al., 1995; 
Larribe et al., 1997; Mellies et al., 1997; Rosenshine et al., 1996). The conditions necessary 
for expression of type IV fimbriae differ between species and probably reflect the different 
niches (Dougherty and Smith, 1999; Fullner and Mekalanos, 1999; Larribe et al., 1997).
Although promoters similar to the putative fimbriae (apf) promoter sequence were highly 
active under routine growth conditions in vitro (Doree and Mulks, 2001), the apf promoter 
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required specific conditions for activity and was subject to environmental regulation (Chapter 
5). The factors that control fimbriae expression in A. pleuropneumoniae are unknown. As 
discussed above, host factors can induce expression of fimbriae in A. pleuropneumoniae both 
in vitro and in vivo. In addition, fimbriae expression was found to be related to growth phase 
and medium. We cannot conclude whether fimbriae induction in A. pleuropneumoniae was 
directly growth phase dependent or whether it was due to deprivation of a specific essential 
nutrient. Quorum factors, temperature and iron or NAD concentration had no or minor 
effects on apf promoter activity. Quorum factors are specific extracellular substances that 
may influence gene transcription in a bacterial density dependent manner and are produced 
by many bacteria including A. pleuropneumoniae (Malott and Lo, 2002). The role of NAD 
concentration in fimbriae expression appears to be serotype specific. In A. pleuropneumoniae 
serotypes 5a, 9 and 10 but not in serotypes 1 and 2 NAD restriction is a critical factor for 
fimbriae expression (Chapter 5; Van Overbeke et al., 2002).
Molecular mechanisms of regulation of gene transcription include two-component 
systems and alternative sigma factors. Sigma factors are specific RNA polymerase initiation 
factors which are essential for transcription of various genes. In the apf promoter region, a 
putative σ70 and not a putative σ54 promoter sequence was identified. Although most known 
type IV subunits are transcribed from σ54 promoters, several type IV subunits are transcribed 
from a σ70 promoter. The major subunit gene pilE in Neisseria species utilises a σ70 promoter 
and expression of PilE is regulated by PilA, PilB and RegF (De Reuse and Taha, 1997; 
Fyfe et al., 1995; Larribe et al., 1997). The environmentally regulated bundle-forming pili 
of enteropathogenic Escherichia coli are also transcribed from a conventional σ70 promoter. 
Here, expression of pili is regulated by BfpT (Martinez-Laguna et al., 1999; Puente et al., 
1996). The A. pleuropneumoniae genome (unfinished genome available through BLAST) 
appears to contain homologues of PilR and PilS that are involved in the regulation of the 
major fimbriae subunit gene pilA of P. aeruginosa. PilS and PilR belong to the family of two-
component transcriptional regulatory systems that have been described in many bacterial 
species. When stimulated by the appropriate environmental signals, the sensor protein PilS 
activates PilR through kinase activity. PilR then activates transcription of the major subunit 
gene pilA, probably by interacting with RNA polymerase containing σ54 (Alm and Mattick, 
1997). As the apf genes do not appear to be under control of σ54, the possible role of the 
PilR and PilS homologues in regulation of A. pleuropneumoniae fimbriae expression awaits 
further investigation.
Although expression of fimbriae in A. pleuropneumoniae is induced in vivo and upon 
CHAPTER 6
100 101
GENERAL DISCUSSION
host-cell-contact, the function of these fimbriae is unknown. Fimbriae or pili can mediate 
adherence in a number of pathogens and are expressed by several disease causing species of 
the Pasteurellaceae (Kachlany et al., 2001; Nika et al., 2002; Ruffolo et al., 1997; van Alphen, 
1995). Adherence is regarded as an important first step in the microbial colonisation of the 
host. Type IV fimbriae form an unique class of fimbriae which can display many functions, 
but their contribution in virulence lies primarily in their ability to promote attachment to 
various types of receptors during tissue colonisation (Strom and Lory, 1993). Although 
expression of fimbriae was found in A. pleuropneumoniae adhering to LEC (Chapter 5), 
infection experiments with fimbriated recombinant A. pleuropneumoniae S4074 (pGZRS-
F1) yielded similar adherence levels as obtained for the strain lacking fimbriae under the 
conditions employed (Chapter 4). The most simple explanation for this is that fimbriae are 
not involved in adherence. However, the induction of fimbriae expression upon cell contact 
suggests a role for fimbriae in adherence. The fimbriae-mediated adherence may be masked 
by activity of other bacterial surface adhesins. Another possibility is that fimbriae-mediated 
adherence of A. pleuropneumoniae requires a tip-located adhesin (Alm et al., 1996; Nassif et 
al., 1994; Serino and Virji, 2000) that is not encoded for in the operon expression construct 
described in Chapter 4. Another explanation may lay in the use of the LEC culture system for 
adherence studies. In contrast to our results, Van Overbeke et al. (2002) found a relationship 
between adherence of A. pleuropneumoniae to alveolar epithelial cells (AEC) and fimbriae 
expression. Although the type of these fimbriae is unknown, LEC and AEC may differ in their 
expression of cell surface structures that are exploited as receptors by A. pleuropneumoniae 
fimbriae. Alternatively, type IV fimbriae of A. pleuropneumoniae mediate adherence to other 
cell types (e.g. tracheal epithelial cells). Adherence is only one of many features displayed by 
type IV fimbriae. One other feature is the uptake of DNA in e.g. H. influenzae (Dougherty and 
Smith, 1999). As in A. actinomycetemcomitans (Wang et al., 2002), natural transformation 
was not observed in A. pleuropneumoniae, irrespective of fimbriae expression (unpublished 
data). In vitro and in vivo experiments with apfA deletion mutants of A. pleuropneumoniae 
are necessary to learn more about the function of fimbriae of A. pleuropneumoniae.
The major subunit ApfA contained many of the characteristics shared by type IV subunits. 
The most striking difference of ApfA was the presence of an alanine residue instead of the 
consensus glycine at position -1 relative to the ApfA cleavage site. Although both amino 
acids are neutral, nonpolar and similar in structure (alanine contains an extra methyl group), 
substitution of Gly (-1) with Ala (-1) in mutational analysis of the major subunit PilE of P. 
aeruginosa, strongly reduced cleavage of prepilin monomers and blocked subsequent pilus 
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assembly (Strom and Lory, 1991). Substitutions of Gly (-1) with other residues resulted in 
a complete lack of subunit processing (Strom and Lory, 1991). The implications of the Ala 
(-1) in ApfA are not clear. Possibly, ApfA is cleaved at a reduced efficiency or the cleavage 
characteristics of the prepilin peptidase ApfD are different in comparison with prepilin 
peptidases of other bacteria. The latter is not unlikely since the homology between prepilin 
peptidases of different bacterial species is low. We found that expression of the apfABCD 
genes resulted in intact fimbriae and therefore we assume that ApfA subunits harbouring 
Ala (-1) can be processed and assembled into intact fimbriae. The major subunit PilE
L
 from 
Legionella pneumophila also contains an Ala (-1) and can be assembled into fimbriae (Stone 
and Abu Kwaik, 1998). This suggests that the typical characteristics of the type IV pili 
biogenesis are perhaps less strict than previously assumed.
The amino acid sequences of type IV subunits identified in various species share 
similarities, which are mainly located in a small hydrophobic area within the amino terminus. 
Type IV pilus genes can be found throughout the genome or clustered in an operon although 
the orientation and location of the different genes can differ. In A. pleuropneumoniae, 
fimbriae biogenesis requires the products of the apfABCD genes and the genetic organisation 
was identical to fimbriae operons in A. actinomycetemcomitans, H. influenzae and P. 
multocida. Several type IV clusters contain numerous additional genes involved in regulation 
and biogenesis of fimbriae (Alm and Mattick, 1997; Marsh and Taylor, 1999; Srimanote et 
al., 2002; Stone et al., 1996; Tonjum and Koomey, 1997). Together with the wide spread 
distribution of type IV pilus genes in many unrelated species, these facts strongly suggest 
that an ancient gene common to many species has diverged, leaving little similarity among 
its variants except at the amino terminus.
Contribution of RTX toxins to A. pleuropneumoniae infection
In addition to factors contributing to colonisation in vivo, A. pleuropneumoniae produces 
several factors that counteract phagocytosis by host immune cells and killing by antibody and 
complement. Impairment of the host immune system by Apx toxins, is an important virulence 
trait of A. pleuropneumoniae. Killing of neutrophils and macrophages by Apx toxins probably 
disables the host to clear A. pleuropneumoniae from the lungs (Dom et al., 1992a; Dom et al., 
1992b; Udeze and Kadis, 1992). In addition, Apx toxins cause tissue injury and subsequent 
lesions through lysis of host cells and induction of oxidative burst in neutrophils and 
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macrophages (Dom et al., 1992a; Dom et al., 1992b; Kamp et al., 1997; Udeze and Kadis, 
1992). The ability to produce more than one Apx toxin varies among the different serotypes 
of A. pleuropneumoniae and raises questions about their contribution to the pathogenesis. 
Particularly ApxII, which is produced by nearly all strains, is of interest. ApxII exhibits only 
weak toxicity in vitro and purified ApxII is much less potent to induce lesions in vivo than 
ApxI and ApxIII when instilled endobronchially (Kamp et al., 1991; Kamp et al., 1997). 
However, A. pleuropneumoniae strains of serotypes 7 and 12 and chemically or transposon 
induced mutant strains of serotypes 1 and 5 which produce in vitro ApxII only, are still able 
to cause severe disease with typical lung lesions (Prideaux et al., 1999; Reimer et al., 1995; 
Tascon et al., 1994). Together, these data led us to asses the relative contribution of ApxI and 
ApxII in the pathogenesis by testing the ability of different toxin mutants to induce lesions 
and clinical disease (Chapter 2). Apx mutants, that produce in vitro either ApxI or ApxII only, 
are still able to cause lesions and clinical disease but not as consistently as is seen with the 
parent strain. A complete lack of virulence was observed in mutants lacking both ApxI and 
ApxII stressing the essential role of these toxins in the development of clinical symptoms 
and lesions.
The potency of the ApxI deletion mutant of serotype 1 (S4074 ΔapxIA) to induce clinical 
symptoms and lesions (Chapter 2) was unexpected in view of in vivo instillation experiments 
with purified toxins and in vitro toxicity (Kamp et al., 1991; Kamp et al., 1997). Moreover, 
strains of serotype 10 produce in vitro ApxI only and belong to the most virulent strains. 
In addition to a critical role of toxins in the pathogenesis, adhesins may contribute to the 
virulence of the tested strains. Close contact with target cells may lead to a local high 
concentration of toxins and thereby enhance survival of the bacteria in vivo. Interestingly, 
S4074 ΔapxIA induced in vitro a delayed but two times higher oxidative burst in neutrophils 
compared to the parent strain or the ApxII deletion mutant (S4074 ΔapxIIA) (Jansen et al., 
1995). The higher induced activity in neutrophils by S4074 ΔapxIA may be explained by 
the dependency of ApxII on export proteins encoded by ΔapxIBD. A lack of competition for 
export in S4074 ΔapxIA might result in a higher secretion of ApxII compared to the parent 
strain. Production of ApxI was unaltered in S4074 ΔapxIIA (Jansen et al., 1995). However, 
S4074 ΔapxIA produced in vitro lower levels of ApxII than the parent strain (Jansen et al., 
1995). This suggests that the level of oxidative burst in neutrophils is inversely related 
to ApxII concentration. The higher reactivity in neutrophils induced by S4074 ΔapxIA 
might result in an overall higher production of oxygen radicals in vivo and thus more 
damage to host tissue. This idea is supported by observations that high concentrations of A. 
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pleuropneumoniae or cell-free culture supernatant were lytic, whereas low doses induced 
increased oxidative metabolism in neutrophils and alveolar macrophages (Dom et al., 1992a; 
Dom et al., 1992b; Udeze and Kadis, 1992). The inverse relation between Apx concentration 
and neutrophil activity is further supported by several reports on RTX toxins of E. coli, M. 
haemolytica and A. actinomycetemcomitans, where low concentrations of toxins exhibited 
profound effects on normal cell functions, including release of leukotrienes, interleukins and 
lysosomal content, and enhanced oxidative burst (Bhakdi and Martin, 1991; Cavalieri and 
Snyder, 1982; Konig et al., 1994; Narayanan et al., 2002; Welch, 1991; Welch et al., 1995). 
Together, this can explain our observation that infection of pigs with S4074 ΔapxIA induced 
lesions in two out of three animals. However, since no information is available on the in vivo 
production level of ApxI and ApxII, we cannot exclude a difference in expression level of 
the various Apx toxins in vivo compared to in vitro. The data suggest that ApxI and ApxII act 
differently but are equally important in the pathogenesis and that the in vivo production level 
of each toxin may be a critical factor.
Concluding remarks
In this thesis we have shown that A. pleuropneumoniae efficiently adheres to lung 
epithelial cells suggesting that adherence to the lower respiratory tract epithelium is an 
important first step in the colonisation of the host. Although bacterial contact to eukaryotic 
cells induces expression of fimbriae, factors contributing to adherence remain to be elucidated. 
Infection experiments with Apx deletion mutants indicated that ApxII is as important as ApxI 
in the pathogenesis. Their different action and/or production level in vivo may be critical. 
In current available vaccines ApxI, ApxII and ApxIII are essential for protection against the 
clinical symptoms caused by A. pleuropneumoniae infections. However, they do not prevent 
colonisation. To obtain full protection additional proteins should be included into these 
vaccines. The type IV fimbriae of A. pleuropneumoniae could be a candidate to include in 
subunit vaccines: i) Fimbriae are expressed on the surface of the bacteria and are likely to be 
immunogenic. ii) Fimbriae are potential virulence factors and are induced in vivo and upon 
cell contact. This can be important to exclude selection of escape mutants under vaccine 
pressure. iii) The fimbrial subunit appears to be highly conserved among all serotypes 
suggesting that it is suitable for one vaccine against all serotypes. iv) Purified fimbriae of 
other pathogens have been shown to confer protection (Desjardins et al., 1996; Evans et 
al., 1992; Langermann et al., 1997; Lepper et al., 1992; O’Meara et al., 1993; Palaszynski 
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et al., 1998; Sirakova et al., 1994). Together, these data make the type IV fimbriae of A. 
pleuropneumoniae an attractive vaccine candidate.
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Actinobacillus pleuropneumoniae causes porcine pleuropneumonia, a disease that occurs 
world-wide and affects growing pigs of all ages. Infection of pigs with A. pleuropneumoniae 
can result in high morbidity and mortality. Based on antigenic diversity of capsule and 
lipopolysaccharide [LPS] composition, 15 serotypes of  A. pleuropneumoniae have been 
identified. All serotypes can cause severe disease and death in pigs. Currently available 
vaccines are based on whole cell bacterin or are subunit vaccines containing the RTX toxins 
ApxI, ApxII and ApxIII. As the available vaccines do not fully prevent the economic losses 
associated with the disease, work continues to improve vaccines that provide complete 
protection. Several factors have been identified that enable the bacterium to survive in the host 
but more knowledge concerning the role in the pathogenesis of virulence factors is required 
to improve available vaccines against A. pleuropneumoniae. In this thesis we addressed this 
topic by studying the role of RTX toxins, LPS and fimbriae in the pathogenesis.
The RTX toxins ApxI, ApxII and ApxIII are essential for the development of clinical 
symptoms and lesions typical for A. pleuropneumoniae infections. These Apx toxins are 
involved in impairment of host-defence mechanisms by their toxic effect on alveolar 
macrophages and neutrophils. Most serotypes of A. pleuropneumoniae produce in vivo 
more than one toxin. To assess the surplus value of the production of more than one toxin 
and the relative contribution of ApxI and ApxII to the infection, the ability of different Apx 
mutants of A. pleuropneumoniae serotype 1 to induce lesions was investigated (Chapter 2). 
Infection of pigs with isogenic strains unable to produce or secrete both ApxI and ApxII did 
not result in pathological lesions, indicating that both toxins are essential for the pathogenesis 
of pleuropneumonia. Infection with single toxin deletion mutants did not consistently result 
in lesions and clinical symptoms as was seen for the parent strain. Strikingly, ApxII seemed 
at least as potent as ApxI in the development of clinical and pathological symptoms. Only 
one out of four pigs inoculated with an ApxII mutant strain developed mild pneumonia 
whereas two out of three pigs inoculated with an ApxI mutant strain developed more severe 
lesions. The results indicate that both ApxI and ApxII of A. pleuropneumoniae serotype 1 are 
necessary for full virulence and that ApxI and ApxII are equally important in the pathogenesis 
of A. pleuropneumoniae serotype 1.
Adherence to host tissue is regarded as an important first step in the colonisation of 
the host. In vivo after intranasal inoculation, A. pleuropneumoniae has been shown to be 
associated with lower respiratory epithelium. In this thesis, we describe an in vitro infection 
model to study the interaction of A. pleuropneumoniae with primary cultures of porcine lung 
epithelial cells [LEC] (Chapter 3). Results with LEC were compared with data obtained 
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with swine kidney cells [SK6]. Adherence of A. pleuropneumoniae to LEC was more rapid 
and 30-fold more efficient than adherence to SK6 cells stressing the importance of using 
organ specific cells. The efficient binding of A. pleuropneumoniae to LEC indicates that 
adherence to epithelial cells in the lower respiratory tract may constitute an important step in 
the pathogenesis. In search for the mechanism of the adherence event, the role of LPS was 
investigated because of reports about its involvement in adherence of A. pleuropneumoniae 
to frozen tracheal sections. Mutants lacking the O-antigen of LPS demonstrated 
increased adherence to LEC suggesting that O-antigens mask adhesins. Adherence of A. 
pleuropneumoniae to LEC was not affected by changes in the core region of LPS. These data 
indicate that LPS and particularly the O-antigen is not essential in adherence to LEC. This 
conclusion was confirmed by the finding that adherence of A. pleuropneumoniae could not 
significantly be inhibited by LPS. Apparently different adhesins are involved in adherence 
of A. pleuropneumoniae to living LEC or frozen trachea. The in vitro infection of primary 
cultures of lower respiratory epithelium is a valuable model in studying the pathogenesis of 
A. pleuropneumoniae.
In an attempt to identify factors involved in adherence of A. pleuropneumoniae, we 
focussed on fimbriae. Fimbriae mediate adherence in a number of species and have been 
isolated recently from A. pleuropneumoniae. The genome of A. pleuropneumoniae was 
found to contain at least four genes involved in type IV fimbriae biogenesis (Chapter 4). 
The first gene encodes the fimbrial subunit, the other genes encode proteins involved in 
processing and assemblage of subunits into intact fimbriae. A putative promoter sequence 
was identified upstream of the gene cluster. However, expression of fimbriae was not found 
in A. pleuropneumoniae under various growth conditions. To assess the functionality of 
the fimbriae genes, the complete gene cluster was placed under an active promoter in an 
expression vector and transferred to A. pleuropneumoniae. Expression of the fimbriae genes 
from this vector resulted in fimbrial subunits and in fimbriae protruding from the bacterial 
cell surface. These data indicate that A. pleuropneumoniae carries an intact fimbrial operon 
but that under routine laboratory growth conditions the promoter activity may be insufficient 
to stimulate the formation of intact fimbriae. The involvement of fimbriae in adherence to 
LEC could not be demonstrated.
The fimbrial subunit protein ApfA contains many of the features shared by type IV 
subunits but is remarkably different with respect to the cleavage site. ApfA contains an 
alanine at position -1 from the cleavage site in contrast to the consensus glycine at this 
position. Substitution of the consensus glycine (-1) with alanine (-1) in PilE of Pseudomonas 
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aeruginosa has been shown to block the assembly of subunits into intact pili. The presence of 
alanine (-1) appears to be an intrinsic trait of ApfA and does not preclude fimbriae biogenesis 
since expression of the complete operon resulted in intact fimbriae.
The apparent lack of fimbriae expression under routine laboratory growth conditions 
led us to investigate the conditions necessary for fimbriae promoter activity (Chapter 5). 
The fimbriae promoter region was cloned upstream of promoterless luciferase genes in a 
promoter trap vector. This promoter trap vector allows quantification of reporter protein 
expression and therefore the relative strength of the promoter driving the expression both 
in vitro and in vivo in A. pleuropneumoniae. The fimbriae promoter appears to be intact but 
is subject to regulation. Expression of the fimbriae promoter depended on the growth phase 
and was seen only in chemically defined medium. Variation of growth conditions had only 
minor or no effect. To test more native conditions, activity of the fimbriae promoter was 
tested in the presence of LEC. A strong induction of fimbriae promoter activity was observed 
for A. pleuropneumoniae that were adhering to primary cultures of LEC. This interesting 
finding indicates that contact with epithelial cells may be a trigger for fimbriae production. 
The importance of a more natural setting for the induction of fimbriae promoter activity 
was further underlined by our finding that the fimbriae promoter was active in vivo after 
endobronchial inoculation of pigs.
The present work contributes to the understanding of the pathogenesis of A. 
pleuropneumoniae by providing important novel insights into several major virulence 
traits of the pathogen. The production of more than one toxin enhances virulence of A. 
pleuropneumoniae. On the basis of our results with LEC, LPS seems not to be involved in 
adherence of A. pleuropneumoniae to cells of the lower respiratory tract. Type IV fimbriae 
have been identified as novel, potential virulence factors of A. pleuropneumoniae. These 
fimbriae may be very attractive candidates to include in subunit vaccines perhaps in 
combination with the different inactivated toxins. Further in vivo infection experiments with 
various mutants are needed to determine the role of the identified virulence factors in the 
pathogenesis of A. pleuropneumoniae. Vaccination challenge experiments are required to 
determine the potential of the identified virulence factors as vaccine components.
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Actinobacillus pleuropneumoniae is een Gram-negatieve bacterie die longontsteking 
veroorzaakt bij varkens. Deze besmettelijke ziekte komt over de gehele wereld 
voor en veroorzaakt veel schade in de varkenshouderij. Infectie van biggen met A. 
pleuropneumoniae wordt beschouwd als een van de meest voorkomende oorzaken van acute 
luchtwegaandoeningen. Acute (klinische) uitbraken van de ziekte worden gekarakteriseerd 
door een hoog percentage zieke dieren en veel sterfte. De biggen kunnen beschermd 
worden tegen de ziekteverschijnselen door ze te vaccineren met bijvoorbeeld de toxinen 
van A. pleuropneumoniae. Echter, kolonisatie van biggen met A. pleuropneumoniae wordt 
door deze vaccins niet voorkomen. De bacterie kan zich daardoor blijven handhaven in de 
populatie en kan zo niet-gevaccineerde biggen ziek maken. Om de beschikbare vaccins 
te kunnen verbeteren, is meer kennis nodig van factoren van A. pleuropneumoniae die 
bijdragen aan het ziekteproces. Van A. pleuropneumoniae komen 15 verschillende serotypen 
voor die onderscheiden kunnen worden aan de hand van verschillende structuren op de 
buitenkant van de bacterie (kapsel en lipopolysaccharide [LPS]). Hoewel er verschillen 
bestaan in het vermogen waarmee deze serotypen ziekte kunnen veroorzaken (virulentie), 
zijn ze allemaal in staat ernstige ziekteverschijnselen te veroorzaken die zelfs tot de dood 
kunnen leiden. De moleculaire mechanismen die nodig zijn voor een succesvolle infectie 
met A. pleuropneumoniae zijn nog niet volledig bekend. Er zijn meerdere factoren van de 
bacterie beschreven die bijdragen aan de overleving en vermenigvuldiging van de bacterie in 
zijn gastheer en aan het ontstaan van ziekteverschijnselen. In dit proefschrift hebben we de 
rol in het ziekteproces van de toxinen, het LPS en de fimbriae nader onderzocht.
A. pleuropneumoniae produceert vier verschillende toxinen genaamd ApxI, ApxII, ApxIII 
en ApxIV. Drie van deze Apx toxinen zijn essentieel voor de ontwikkeling van klinische 
symptomen en beschadigingen in de long (laesies) die karakteristiek zijn voor infecties 
met A. pleuropneumoniae. De Apx toxinen kunnen longmacrofagen en neutrofielen doden 
en spelen op deze manier een belangrijke rol in het ontwijken en onschadelijk maken van 
het eerste verdedigingsmechanisme van de gastheer: fagocytose en afdoding. De bijdrage 
van de individuele toxinen aan het infectieproces is echter onduidelijk omdat verschillende 
serotypen verschillende combinaties van toxinen produceren. In Hoofdstuk 2 hebben we de 
bijdrage bepaald van de toxinen ApxI en ApxII in de ontwikkeling van klinische symptomen 
en longlaesies. Hiervoor zijn mutanten van A. pleuropneumoniae serotype 1 gebruikt waarin 
één of twee toxine genen (apxICA en apxIICA) of de toxine export genen (apxIBD) zijn 
uitgeschakeld. Infectie van biggen met stammen die zowel ApxI als ApxII niet kunnen 
produceren of uitscheiden, resulteerde niet in de vorming van laesies en de bacteriën konden 
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niet geïsoleerd worden uit geïnfecteerde biggen. Dit geeft aan dat de toxinen essentieel zijn 
voor het ziekteproces. Stammen waarin slechts één van de twee toxine genen (apxICA of 
apxIICA) is uitgeschakeld, konden nog wel laesies en klinische symptomen opwekken 
maar niet zo consistent als de ouderstam die beide toxinen produceert. Uit deze resultaten 
blijkt dat beide toxinen van A. pleuropneumoniae serotype 1 nodig zijn voor een maximale 
capaciteit om ziekte te veroorzaken. Opmerkelijk is dat ApxII net zo goed laesies en klinische 
symptomen kan opwekken als ApxI. Uit eerdere studies met andere serotypen bleek dat 
ApxII minder bijdraagt dan ApxI aan de ontwikkeling van laesies in dierexperimenten 
met gezuiverd toxine en aan de toxiciteit in vitro. Een mogelijke verklaring is dat het 
productieniveau of de werking van deze toxinen in de long onderling verschilt.
Algemeen wordt aangenomen dat hechting van A. pleuropneumoniae aan luchtweg 
epitheel een belangrijke eerste stap is in de kolonisatie van de gastheer. Hechting verhoogt de 
mogelijkheid voor de bacteriën om zich te handhaven. In diverse in vitro studies is de binding 
van A. pleuropneumoniae onderzocht aan epitheel van de bovenste luchtwegen (trachea-
epitheel) waarbij LPS een rol bleek te spelen. Echter, kort na infectie van biggen worden 
hechtende bacteriën voornamelijk gevonden aan epitheel van de onderste luchtwegen 
(longepitheel). Daarom hebben we een in vitro infectiemodel opgezet dat gebruik maakt 
van primaire kweken van longepitheel cellen [LEC] (Hoofdstuk 3). Resultaten verkregen 
met deze cellen hebben we vergeleken met data verkregen met varkensniercellen [SK6]. 
A. pleuropneumoniae bleek sneller en tot 30-maal efficiënter te binden aan LEC dan aan 
SK6. Deze resultaten benadrukken dat orgaanspecifieke cellen gebruikt moeten worden 
voor onderzoek naar bindingsfactoren (adhesines) van A. pleuropneumoniae. Daarnaast 
lijkt binding van A. pleuropneumoniae aan longepitheel een belangrijke factor te zijn in 
het infectieproces. De mogelijke rol van LPS in de binding aan LEC werd onderzocht met 
behulp van A. pleuropneumoniae mutanten waarin genen, die betrokken zijn bij de aanmaak 
van LPS, zijn uitgeschakeld. LPS bevindt zich aan de buitenkant van de bacterie en is 
opgebouwd uit O-antigeen (keten van suikers), lipid A (voor verankering in de membraan) en 
kerngedeelte (vormt de schakel tussen O-antigeen en lipid A). Mutanten die geen O-antigeen 
van het LPS produceren vertoonden een licht verhoogde binding aan LEC. Dit suggereert 
dat de O-antigenen adhesines maskeren. Verandering van het kerngedeelte van het LPS had 
geen effect op de bindingsefficiëntie. LPS en vooral het O-antigeen lijkt niet betrokken te zijn 
bij binding van A. pleuropneumoniae aan LEC. Verder bewijs voor de LPS-onafhankelijke 
binding aan LEC werd geleverd door de onveranderde binding van A. pleuropneumoniae 
aan LEC in aanwezigheid van gezuiverd LPS. Mogelijk produceert A. pleuropneumoniae 
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verschillende factoren die aan een specifiek cel type kunnen binden. Het gebruikte in vitro 
infectiemodel met LEC is waardevol in het onderzoek naar factoren die een rol spelen in het 
infectieproces van A. pleuropneumoniae.
Bacteriën kunnen zeer verschillende adhesines produceren. Haarvormige structuren op de 
oppervlakte van de bacterie genaamd fimbriae of pili zorgen voor binding aan gastheerweefsel 
in een aantal bacteriesoorten. Onlangs zijn fimbriae ook gevonden in A. pleuropneumoniae, 
zij bleken tot de type IV familie van fimbriae te behoren. Naast een rol in binding aan 
gastheerweefsel, hebben type IV fimbriae in andere bacteriesoorten verschillende andere 
functies, bijvoorbeeld de opname van DNA. Omdat de fimbriae mogelijk een rol spelen in A. 
pleuropneumoniae infecties, hebben we genen, die betrokken zijn bij de productie van deze 
fimbriae, opgespoord en onderzocht (Hoofdstuk 4). Het genoom van A. pleuropneumoniae 
bleek vier genen te bevatten die betrokken zijn bij de productie van fimbriae. Eén gen codeert 
voor de subunit waaruit de fimbriae zijn opgebouwd (ApfA), de andere genen coderen voor 
eiwitten die betrokken zijn bij de processing en assemblage van de fimbriae. Deze genen 
worden voorafgegaan door een mogelijke promotor. Een promotor bepaalt, afhankelijk van 
de omstandigheden, of genen aan of uit staan. Ondanks de aanwezigheid van fimbriae genen 
in het genoom, konden fimbriae niet aangetoond worden onder verschillende groeicondities 
van A. pleuropneumoniae. Om te bewijzen dat de gevonden genen wel degelijk betrokken 
zijn bij de productie van fimbriae, hebben we de vier genen geplaatst achter een sterke 
promotor op een plasmide. Deze promotor zorgde voor het aanschakelen van de fimbriae 
genen wat resulteerde in haarvormige structuren op de oppervlakte. Dit betekent dat de genen 
functioneel zijn en dat de eigen fimbriae promotor waarschijnlijk onderhevig is aan regulatie. 
De aanwezigheid van fimbriae had geen invloed op binding van A. pleuropneumoniae aan 
LEC. De functie van de fimbriae in A. pleuropneumoniae is nog niet bekend.
Het subunit ApfA heeft vele eigenschappen die karakteristiek zijn voor type IV subunits, 
maar verschilt van deze subunits rond de plaats waar het signaal peptide eraf geknipt wordt. 
Dit signaal peptide moet verwijderd worden voordat het subunit ingebouwd kan worden 
in fimbriae. Op positie -1 van de knipplek in ApfA zit het aminozuur alanine in plaats 
van glycine. In andere micro-organismen is gebleken dat dit een blokkade vormt voor 
het knipproces en dus voor de productie van fimbriae. Echter, in A. pleuropneumoniae 
werden fimbriae waargenomen nadat de vier fimbriae genen door een sterke promotor 
waren aangeschakeld. Blijkbaar vormt alanine op positie -1 van de knipplek in ApfA geen 
belemmering voor de productie van fimbriae in A. pleuropneumoniae.
Bacteriën zijn in staat zich snel aan te passen aan de veranderende omstandigheden in hun 
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omgeving. Dit doen ze door genen aan of uit te schakelen met behulp van een bijbehorende 
promotor. De fimbriae promotor lijkt onder normale groeiomstandigheden uit te staan. Om te 
bepalen of fimbriae van A. pleuropneumoniae belangrijk kunnen zijn voor het infectieproces, 
hebben we onderzocht onder welke condities de fimbriae promotor aanstaat ofwel fimbriae 
geproduceerd worden. Daarvoor hebben we gebruik gemaakt van luciferase genen. De 
eiwitten waarvoor deze genen coderen produceren in de aanwezigheid van een substraat licht. 
Door de fimbriae promotor voor de luciferase genen te plaatsen, kunnen we heel gemakkelijk 
de activiteit van die promotor bepalen onder verschillende omstandigheden (Hoofdstuk 5). 
Met dit systeem hebben we ontdekt dat de promotor van de fimbriae genen intact is maar 
dat deze alleen onder specifieke omstandigheden aanstaat, namelijk wanneer de bacteriën 
groeien in chemisch gedefinieerd medium. Om een meer natuurlijke situatie na te bootsen, 
is de activiteit van de promotor ook getest in de aanwezigheid van LEC. Hieruit bleek dat 
de promotor alleen aan stond in bacteriën die gehecht waren aan epitheel cellen. Blijkbaar 
is het contact van A. pleuropneumoniae met LEC een signaal om de fimbriae promotor aan 
te schakelen. Om te testen of de fimbriae promotor ook aan staat tijdens infectie, zijn enkele 
biggen geïnfecteerd met A. pleuropneumoniae. Kort na infectie bleek de fimbriae promotor 
ook aan te staan in bacteriën die aanwezig waren in longweefsel. Fimbriae worden blijkbaar 
tijdens infectie geproduceerd en zijn daarom mogelijk van belang voor het infectieproces.
Dit onderzoek laat zien dat de interactie van A. pleuropneumoniae met zijn gastheer 
zeer dynamisch is waarbij meerdere factoren betrokken zijn. De productie van meerdere 
toxinen verhoogt de virulentie van A. pleuropneumoniae. De efficiënte hechting van 
A. pleuropneumoniae aan epitheel cellen van de long draagt mogelijk ook bij aan het 
infectieproces. Deze interactie is onafhankelijk van LPS. Daarnaast wordt de productie van 
fimbriae aangeschakeld wanneer bacteriën hechten aan longepitheel cellen en tijdens infectie. 
De fimbriae vormen mogelijk een nieuwe virulentie factor van A. pleuropneumoniae en zijn 
een goede kandidaat om aan bestaande toxine vaccines toe te voegen. Uit de literatuur blijkt 
dat soortgelijke fimbriae van andere organismen bescherming kunnen geven tegen infecties 
veroorzaakt door die organismen. Of fimbriae van A. pleuropneumoniae ook bescherming 
bieden tegen A. pleuropneumoniae infecties moet nog onderzocht worden.
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Dit proefschrift was er uiteraard niet gekomen zonder de hulp van velen. Ik wil hier 
iedereen bedanken die ook maar enigszins heeft bijgedragen aan de totstandkoming van dit 
proefschrift met extra handjes, extra hersens of wat afleiding. Een aantal van hen wil ik extra 
bedanken voor hun inzet en bijdrage.
Laat ik beginnen bij mijn begeleiders op het ID. Hilde, ook al ben je er pas halverwege 
bij gekomen voor wat hulp op het moleculair biologische vlak, het kwam al snel neer op de 
volledige begeleiding. Je werd tot je eigen verbazing zelfs de enige co-promotor. Je wist in 
het begin nog maar weinig van App en we hadden allebei geen idee naar welke adhesie factor 
we op zoek waren. Desondanks ging je er volledig voor. Je wist altijd de juiste prioriteiten 
te stellen en onze samenwerking met betrekking tot het schrijven en corrigeren van artikelen 
heb ik erg gewaardeerd. Elbarte, het opzetten van het celmodel om binding te testen verliep 
moeizaam en dat heeft je vast wat grijze haren opgeleverd. Is dat de reden geweest waarom 
je van coupe veranderde? Uiteindelijk is er een bruikbaar celmodel uit gekomen waar we 
best trots op kunnen zijn. Norbert, jouw bijdragen zijn van groot belang geweest voor mijn 
onderzoek. Vooral voor het celmodel hebben we veel gediscussieerd en geprobeerd. Je nam 
ook de moeite om met mij in Utrecht nieuwe technieken uit te proberen, die helaas niet altijd 
even succesvol bleken. Zo hebben we in de dierproef “het licht” niet gezien. Ik ben blij dat 
dankzij jouw inspanningen mijn enige infectieproef van biggen met App geslaagd is.
Dan mijn beide promotoren. Jos Verheijden, je zorgde ervoor dat ik de grote lijnen in de 
gaten hield: is er een tijdsplanning en wat worden de hoofdstukken? Toen ik meer tijd nodig 
had om het “promotorwerk” af te maken, heb je ervoor gezorgd dat ik die ook kreeg. Af en 
toe was je niet bij het overleg, je had het dan te druk met crisisvragen over bijvoorbeeld 
MKZ: “moeten egeltjes die wakker worden uit hun winterslaap ook geruimd worden?”. 
Jos van Putten, net als Hilde kwam je er later bij in verband met de ontwikkelingen op het 
moleculair biologische vlak. Je had altijd wel weer verrassende ideeën. Het overleg dat het 
laatste jaar bijna maandelijks was, was altijd erg stimulerend en constructief. Ik heb veel 
van je geleerd onder andere met betrekking tot het schrijven van artikelen. Vooral die mooie 
zinnen die wij hebben leren kennen als typische “Jos”-zinnen. Daarnaast waren je correcties 
razendsnel en nauwkeurig (tot in de referenties!).
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Uiteraard bedank ik ook mijn paranimfen. Collega-AIO Astrid, je was een gezellige 
en enthousiaste collega. Altijd belangstellend naar mijn werk en eventueel roddelnieuws. 
Bedankt voor je tips en kritische opmerkingen zowel op het lab als over het schrijven. En 
samen AIO-en is inderdaad leuker, we houden contact (dan kan ik je lastig vallen met 2D-
vragen). Watze, zonder de door jouw aangeraden CD’s was het tellen van bacteriën onder de 
microscoop niet om uit te houden. Nu ik wat meer tijd krijg (?) kom ik vast een keer langs 
voor het maken van een nieuw CD-rek (de oude is namelijk allang vol). Je had vooraf geen 
idee wat het inhield om paranimf te zijn, ik hoop dat je het leuk gevonden hebt.
Ook alle andere collega’s wil ik bedanken. Thea, Johan en Geertje zaten op het 
“luchtaandoeningen lab” waar ik begon met mijn onderzoek. Vooral Thea bedankt, je 
was nooit te beroerd om een paar helpende handen uit te steken. Johan had altijd wel een 
maf verhaal te vertellen. Herma, jij stond altijd klaar om klusjes uit te voeren waar ik 
geen tijd voor had. Ook kon ik altijd bij je terecht met allerhande praktische vragen. Mijn 
kamergenoten Olav en Alieda, en later Henk en Michiel bedankt voor de gezellige tijd. Bij 
Henk en Olav kon ik altijd terecht met computer vragen. Olav, we hebben veel gekletst over 
muziek, hoewel onze smaken niet geheel overeen komen. Alle collega’s van vleugel 26, 17 
en 19, bedankt voor de pauzes met koffie en soms taart. Ik kon altijd wel bij iemand terecht 
voor vragen of een praatje. Alle AIO’s van het ID, de borrels die we hadden waren vaak veel 
te gezellig waardoor opstaan op vrijdagochtend wat zwaarder was dan andere ochtenden.
Voor de hulp bij de perfusie van longen voor de isolatie van epitheelcellen, wil ik Ad en 
Ad bedanken. Op het celkweeklab kon ik rekenen op de hulp van Phreddy, Rob hielp mij bij 
de celkleuringen. Frans, Arie en Lissette bedankt voor het eindeloos proberen en turen naar 
mijn preparaten voor de EM. Uiteindelijk hebben we de fimbriae van App dan toch nog te 
zien gekregen! Jan en Joop, bedankt dat ik jullie mocht lastig vallen met mijn vragen over de 
statistiek. Ook de dierverzorgers bedankt voor die ene dierproef, hij is geslaagd! Bedankt ook 
de mensen van mediabereiding, waar ik altijd chemicaliën kon scoren.
I would like to thank Martha Mulks and Scott Doree for providing the promoter trap 
vectors. It required some persistence to get them intact and working but they have paid off 
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